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ABSTRACT
THE EXPERIENCE OF SCANXIETY IN SURVIVORS OF PANCREATIC CANCER:
A PHENOMENOLOGICAL STUDY
Susan Winebrenner
March 1, 2022
Surveillance scans can signify a crisis point in a cancer patient’s life, provoking
fear and anxiety that negatively impact quality of life. Scan-related anxiety or scanxiety
has been briefly discussed in the literature among lung cancer and lymphoma
populations, but relatively few investigations have studied the psychological impact of
routine surveillance scans during cancer survivorship. The purpose of this study was to
illuminate the lived experience of scanxiety in survivors of pancreatic cancer who have
undergone curative surgical resection. Hermeneutic phenomenology as applied by
Heidegger provided the philosophical underpinnings for this study and van Manen’s
methodological approach was used to guide the research process. Semi-structured
interviews, observations, and field notes from 18 participants were collected and
analyzed to provide an in-depth understanding of the scanxiety experience. Additional
sources of data using art and poetry were used to further illuminate the true essence of the
experience. Thematic analysis uncovered two essential themes: the recurring cycle of
scanxiety and hope for lifelong remission. The recurring cycle of scanxiety was
introduced as a four-stage process and described the complex sequence of events
participants experienced during the time surrounding their surveillance scans. Hope for
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lifelong remission served as the primary objective of survivorship, offering a glimmering
chance of a cure and keeping survivors engaged throughout the cycle.
This study illuminates the intricate relationship between the pancreatic cancer
survivor and their surveillance scan and highlights the complex way in which survivors
experience their scans. The results of this study highlight the need for heightened
awareness among oncology providers to help guide the development of interventions and
improve outcomes across cancer patient populations.
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CHAPTER I
INTRODUCTION
“Scans are like revolving doors, emotional roulette wheels that spin us around for a few
days and spit us out on the other side. Land on red, we're in for another trip to
Cancerland; land on black, we have a few more months of freedom.” (Feiler, 2011).

Background and Significance
For individuals with cancer, the rapid growth in medical imaging performed to
screen, diagnose, and monitor disease has significantly improved rates of survival, yet the
exams themselves can provoke fear and anxiety that negatively impact quality of life
(Grilo et al., 2017; Bui et al., 2022). In a 2011 Time magazine article, cancer survivor
Bruce Feiler introduced the term “scanxiety” to describe the fear and anxiety cancer
patients experience when anticipating upcoming scans and waiting on the results.
Scanxiety is widely reported among healthy individuals undergoing cancer screenings,
(Kitano et al., 2015; Rasmussen et al., 2015), and is briefly discussed in the literature
among lung cancer and lymphoma populations (Bauml et al., 2016; Thompson et al.,
2010), but relatively few researchers have explored the psychological impact of routine
surveillance scans during cancer survivorship. A possible explanation may stem from the
lack of recognition of scanxiety as a legitimate comorbidity in cancer survivorship.
Among non-scholarly sources, scanxiety is widely accepted as a common and distressing
concern for cancer survivors (Alexander, 2020; Patel, 2021). A Google search of the term
yielded over 50,000 hits, and numerous international cancer institutions and cancer1

support networks acknowledge the concept (Bhargava, 2020; Kaplan, 2021; Mulcahy,
2017; Portman, 2019). Despite the term’s popularity, “scanxiety” is not yet part of the
medical lexicon and subsequently is not sufficiently defined, explored, or measured in
published research studies (Bui et al., 2021b; Mulcahy, 2017).
Frequent scanning of cancers associated with a poor prognosis, such as pancreatic
cancer, may provoke more severe symptoms of anxiety and distress. Individuals with
pancreatic cancer experience increased psychological distress, primarily because
pancreatic cancer is largely considered an incurable disease (American Cancer Society
[ACS], 2021b; McGuigan et al., 2018). Only 20% of patients survive the first year after
diagnosis and across all stages of disease, less than 10% will live beyond five years. The
only curative treatment is surgical resection, yet even after surgery, pancreatic cancer will
recur in over 75% of patients. To date, there is no consistently effective treatment for
recurrent pancreatic cancer (Moletta et al., 2019). The National Comprehensive Cancer
Network (NCCN, 2021) guidelines for the management of pancreatic cancer recommend
frequent surveillance scan imaging with Computed Tomography (CT) or Magnetic
Resonance Imaging (MRI) for at least five years following curative surgery. Given the
high rate of disease recurrence, pancreatic cancer survivors are at a high risk for
scanxiety which can significantly impair overall quality of life. To date, there are no
published data on the psychological impact of surveillance CT scans in survivors of
pancreatic cancer.
Gaps in the Literature
In the oncology literature, very few studies examine psychological distress during
the diagnostic phases of cancer survivorship. There are only nine published empirical
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studies to date, and pancreatic cancer populations are not included in any of the studies
(see Appendix A). The absence of pancreatic cancer data is concerning and highlights a
knowledge gap in the literature. Individuals with pancreatic cancer have the lowest
survival rates of any other cancer and have extremely high rates of recurrence, yet the
psychological impact of surveillance scans remains unknown in this population. Another
limitation in the existing literature involves the lack of consistency in existing study
findings. While all nine studies support the existence of scan-related anxiety in cancer
populations, the source of the anxiety is a subject of debate. For example, in two separate
studies using a similar pretest-posttest design, Grilo et al. (2017) and Abreu et al. (2017)
measured anxiety levels immediately before and after routine PET scans in samples of
mixed cancer populations. Grilo et al. found higher levels of anxiety post-scan which
suggests the anticipation of scan results is the primary source of anxiety. In contrast,
patients in the study of Abreu et al. had lower anxiety levels post-scan and identified
scan-specific concerns (e.g., fear of radiation, claustrophobia, etc.) as the main sources of
scan-related anxiety. Research on the clinical and sociodemographic risk factors
associated with scan-related anxiety is even less consistent, as there are contradictory
findings related to age, race, gender, and stage of disease (Bauml et al., 2016; Grilo et al.,
2017; Heyer et al., 2015; LoRe et al., 2016).
A final limitation of the existing literature involves the overuse of cross-sectional
study designs. Six of the nine studies captured levels of anxiety at a single point in time,
generally in the radiology waiting room immediately before an upcoming scan. This
single point in time approach fails to explore the temporal factors that may modulate the
severity of anxiety over the survivorship trajectory. With only three longitudinal studies
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published to date, the impact of time on scan-related anxiety is not well described. There
are no prior studies of anxiety levels for a duration longer than two months nor over a
series of consecutive surveillance scans. Further research is needed to explore the
prevalence and stability of scan-related anxiety over time.
Purpose of the Study
The purpose of this study was to illuminate the lived experiences of scanxiety in
survivors of pancreatic cancer who have undergone curative surgical resection. There is
limited understanding of patient experiences during the diagnostic phases of cancer
survivorship. The goal was to provide an in-depth understanding of the psychological
impact of frequent surveillance scans in survivors of pancreatic cancer. This study
expanded the knowledge of scanxiety from the patient’s perspective and provided insight
into the key factors that exacerbate scan-related anxiety and distress. The knowledge
gained from this study informs future research and provides critical information to
oncology providers, nurses, and mental health professionals to help create targeted
interventions to improve the quality of life across cancer survivorship.
A hermeneutic phenomenological approach provided both the philosophical
framework and methodology underpinning this research (Heidegger, 1962; Husserl 1931;
van Manen, 1990). Participants were asked questions related to their personal experiences
with cancer surveillance scans. Themes and essences that emerged from the data
provided insight into how cancer survivors endure frequent scanning procedures.
Research Question
The research question guiding this study was, “What is the lived experience of
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survivors of pancreatic cancer undergoing cancer surveillance scans after curative cancer
surgery?”
Summary of Chapters
This dissertation is comprised of five chapters. Chapter One presents an
introductory overview of the phenomenon of interest and describes the research problem
in the context of the patient population. This chapter also identifies the gaps in the
existing literature, a justification for the study, and the overall study objectives.
Chapter Two provides an overview of the state of the science related to scanrelated anxiety with an emphasis on individuals with a cancer diagnosis. Key variables
closely related to scan-related anxiety in the literature are discussed. Additional variables
such as cancer-related distress, anxiety in cancer, and fear of cancer recurrence are
examined in the context of a pancreatic cancer diagnosis.
Chapter Three provides an overview of the philosophical framework of
phenomenology, the evolution of hermeneutic phenomenological inquiry, and the
application of phenomenology using van Manen’s (1990) methodological approach. A
detailed description of the research methodology is provided along with a description of
specific study components including the sample, setting, interview guide, procedure, data
analysis plan, protection of human subjects, and trustworthiness of the data.
Chapter Four presents the findings of the thematic analysis from the
phenomenological study. The socio-demographic data of each participant is provided.
Essential themes and corresponding subthemes are defined and discussed. Illustrative
quotes from participants are offered to support the existence of the themes. Alternative
sources of expression using art and poetry are used to illuminate the true essence of the
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themes and to uncover the lived quality of the experience in a fuller and deeper manner.
Finally, a conceptual model of the study themes is presented.
Chapter Five summarizes the key findings derived from the study and compares
and contrasts themes with the current literature. The findings are discussed in the context
of Lee-Jones’s Cancer Recurrence Model (1997) and a modified framework is presented.
The study limitations, significance to nursing, and implications for future research are
presented.
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CHAPTER TWO
LITERATURE REVIEW

“Once I get the [scan] paperwork in the mail, it’s all right there in my mind. And from
that point forward it’s always there gnawing in my mind. It's like waiting to go in front of
a judge that has a sentence for you. Somebody’s making a decision that's going to affect
your life forever. It’s a feeling that your life is completely out of your hands.” (Jake, p. 7,
lines 288-306).

Psychological Distress in Cancer
Individuals with cancer suffer significant psychological burdens related to both
their cancer diagnosis and the uncertainty of their disease. The period following a cancer
diagnosis is fraught with uncertainty about the future. Patients must learn to adapt quickly
to a life full of multiple threats and novel experiences while struggling to resolve the
series of consequential decisions that confront them. Not surprisingly, psychological
distress is common across the cancer trajectory, beginning at diagnosis and extending
into late-stage survivorship (Carlson et al., 2018; Tonsing & Vungkhanching, 2018). The
National Comprehensive Cancer Network (NCCN, 2022) defines psychological distress
as, "a multifactorial unpleasant emotional experience of a psychological (i.e., cognitive,
behavioral, emotional), social, spiritual, and/or physical nature that may interfere with the
ability to cope effectively with cancer, its physical symptoms, and its treatment" (pg. 1).
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Distress exists along a continuum and can range from normal feelings of sadness and
uncertainty to debilitating problems impacting daily life (NCCN, Distress Management,
2022). Psychological distress frequently coexists with other debilitating symptoms such
as the presence of pain, insomnia, irritable mood, fatigue, and impaired concentration.
The negative impact of psychological distress is well-documented in the oncology
literature. Higher levels of distress are associated with non-adherence to treatments,
reduced patient satisfaction, increased functional impairments, inability to work, and
reduced quality of life (Batty et al., 2017; Carlson et al., 2018; Chad-Friedman et al.,
2017; Hellstadius et al., 2017; Lotfi-Jam et al., 2019).
Nearly all patients experience distress at some point throughout their cancer
journey and approximately 50% of patients reach significantly high levels impacting their
daily life (Carlson et al., 2018; Oechsle et al., 2020). The prevalence and severity of
distress can vary according to the sociodemographic, clinical, and treatment-related
factors of the individual. Higher levels of distress occur among individuals who are
female, younger in age, of lower socioeconomic status, have increased symptom burden,
and are receiving aggressive cancer therapies (Lavelle et al., 2017; McMullen et al.,
2018; Syrowatka et al., 2017). Certain cancers with poor prognoses and a high symptom
burden, such as pancreatic and lung cancers, are associated with higher levels of distress
(Saad et al., 2019). The experience of distress can create a considerable comorbidity for
cancer patients and warrant the need for routine screening during key time points to
identify individuals most in need of supportive interventions.
Anxiety in Cancer
For survivors of cancer, psychological distress can manifest as debilitating
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disorders such as anxiety, depression, panic, social isolation, and spiritual crisis (NCCN,
2022). Of these, anxiety is the most prevalent in the clinical setting; over 40% of all
cancer patients meet the diagnostic criteria for anxiety disorder (Berihun, 2017;
Nikbakhsh et al., 2014; Oechsle et al., 2020). Anxiety is defined as an adaptive emotional
reaction characterized by an overwhelming sense of worry, apprehension, or fear over an
impending or anticipated event with an uncertain outcome (Merriam-Webster, 2022). For
a majority of patients, a diagnosis of cancer represents a frightening and stressful event,
filled with anticipatory threats with uncertain outcomes. It is therefore not surprising that
anxiety is a common reaction in individuals with cancer. Anxiety can be linked to a
patient’s psychological reactions to a cancer diagnosis, treatments, possible side effects,
and the uncertainty of the course of the disease (Oechsle et al., 2020). Worries and fears
about disease progression and recurrence are highly prevalent, as up to 87% of patients
report ongoing fears of cancer recurrence (Simard et al., 2013). Even after the cancer is
stabilized, cancer-related anxiety can continue. In fact, anxiety disorders in cancer are
highest in patients who have lived with cancer for more than two years (Götze et al.,
2019; Niedzwiedz et al., 2019).
Fear of Cancer Recurrence
Fear of cancer recurrence (FCR) is a relatively new concept in the literature but
has quickly emerged as an important research topic in the field of psycho-oncology.
Broadly defined as the fear, worry, or concern that cancer will respond poorly to
treatment, progress, or recur elsewhere in the body (Simard et al., 2013; Vickberg, 2003),
FCR is a complex, multidimensional experience that involves numerous cancer-related
concerns including fears of death and further treatments, loss of autonomy, increased pain
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and physical suffering, and becoming a burden to one's family (Şengün İnan & Üstün,
2019). Fears of recurrence are ubiquitous across various subtypes and stages of
malignancy. The research documented that most cancer survivors experience at least
some degree of FCR (Kim et al., 2020). Some of the highest rates are reported in breast
(Fang et al., 2018; Rocque et al., 2021), lung (Lee et al., 2020), ovarian (Ozga et al.,
2015), pancreatic (Petzel et al., 2012), prostate (Friedenreich et al., 2017), and colorectal
cancers (Dang et al., 2019). Recurrence fears can affect individuals at any point during
their cancer trajectory and can last several years after successful cancer treatments
(Custers et al., 2017; Simard et al., 2013).
A fear of cancer recurrence is a well-founded concern, as nearly one-third of
individuals with a cancer diagnosis die of cancer within a 5-year period (ACS, 2021a).
While some degree of FCR is adaptive, (e.g., maintaining routine medical appointments,
vigilance to body symptoms, engaging in a healthy lifestyle), FCR in excess can be
debilitating and is widely known to worsen quality of life (Butow et al., 2018; Dang et
al., 2019; Hall et al., 2019; Tsai et al., 2018). A large and growing body of literature on
the relationship between FCR and quality of life consistently revealed high FCR is
associated with poor functional status (Hedman et al., 2017; Tran et al., 2021),
heightened anxiety (Chen et al., 2018; Tsai et al., 2018; van Eck et al., 2021), intrusive
thoughts (Mutsaers et al., 2016; Zhang et al., 2021), severe depressive symptoms (Liu et
al., 2018), and post-traumatic stress (Moschopoulou et al., 2018). Elevated fears of cancer
recurrence are linked to higher utilization of health care services, i.e., increased
consultations with health care providers, increased emergency room visits, and higher use
of psychotropic medications (Champagne et al., 2018; Lebel et al., 2016).
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Research investigating the severity of FCR over time is limited since a large
number of studies used cross-sectional designs. Of the few longitudinal studies, most are
limited to two years post-diagnosis and demonstrate FCR remains relatively stable over
time (Crist & Grunfeld, 2013; McGinity et al., 2016; Simard et al., 2013). These research
findings are not consistent in the literature, as more recent studies reported significant
decreases in FCR severity over time (Götze et al., 2019, 2020; Leclair et al., 2019; Wu et
al., 2019). The discrepancies in the longitudinal literature may be explained by the chosen
time intervals in which FCR is measured in each study’s design. Most studies assessed
FCR at arbitrary intervals (e.g., 1-month after treatment, 1-year after diagnosis) and not
during key medical time points such as during times of cancer surveillance scans. A
thorough review of the literature revealed only one longitudinal study that investigated
FCR during the time surrounding a cancer surveillance scan. McGinty et al. found
significant changes in FCR during the time surrounding mammograms, with FCR scores
that increased before the mammogram, decreased immediately following receipt of
negative mammogram results, and increased in the month following the mammogram.
Heightened FCR during times of cancer surveillance scans is known to exist anecdotally
(Feiler, 2011), but has been only briefly explored in the medical literature. Given the
limited longitudinal studies exploring FCR during key time points, additional studies are
needed to examine FCR trajectories over time.
Scan-Related Anxiety
Diagnostic imaging is a critical component to screen, diagnose, and follow-up
disease but the exams themselves can provoke fear and anxiety that can significantly
impair quality of life (Lo Re et al., 2016). Among healthy patients undergoing cancer
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screenings, scan-related anxiety is well-documented. For example, in a study exploring
the psychological impact of breast cancer screening in routine mammography, Kitano et
al. (2015) measured anxiety and depression of 312 healthy women who received callback notifications after inconclusive mammographic findings. Significant anxiety and
psychological distress were reported by over 70% of women undergoing routine
screening mammography (Kitano et al., 2015). The reported psychological harms caused
by screening mammography is not a new finding and similar results have been reported
in other cancer screening populations (Loving et al., 2021; Zhang et al., 2020).
Individuals undergoing CT imaging for lung cancer screenings are among the most
widely reported cases of scan-related anxiety. For example, in a study exploring anxiety,
fear of cancer, and perceived risk of cancer among individuals at high risk for developing
lung cancer, Byrne et al. (2008) examined 400 patients undergoing lung cancer screening
CT scans. Individuals with indeterminate and suspicious CT findings suffered significant
long-term psychological distress including increased anxiety, fear of cancer, and
perceived risk of cancer. In another study, van den Bergh et al. (2008) measured anxiety,
discomfort levels, and health-related quality of life in 351 high-risk patients who were
undergoing CT screening for lung cancer. Participants were given surveys at three
distinct time points: 1-day before the scan, 1-day after the scan, and 6-months after the
scan. Although participants reported no specific discomfort related to the CT scan (e.g.,
feelings of claustrophobia, lying still without breathing), there was a significant amount
of distress reported while waiting for the scan results (van den Bergh et al., 2008).
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Scan-Related Anxiety in Cancer Populations
In cancer populations, surveillance scans provide a unique opportunity to study
temporal fluctuations in fear of cancer recurrence and psychological distress. Although
there is a paucity of research investigating the relationship between anxiety and
diagnostic imaging among oncology populations, scan-related anxiety is reported in the
literature (Abreu et al., 2017; Bauml et al., 2016; Grilo et al., 2017; LoRe et al., 2016;
Thompson et al., 2010). Using a convergent mixed-methods approach, Thompson et al.
assessed the psychological impact of surveillance CT scans in 70 long-term lymphoma
survivors. Despite participants representing a largely cured population, 37% of patients
experienced clinically significant anxiety levels at the time of their routine surveillance
scans. The CT scans exacerbated underlying anxiety symptoms, and both a history of
relapse and worse patient-physician relationships were associated with higher anxiety
scores. Subsequent qualitative interviews revealed a fear of cancer recurrence was the
primary source of patient anxiety (Thompson et al., 2010). Similarly, in a study exploring
scan-associated distress among patients with recurrent or metastatic lung cancer, Bauml
et al. measured levels of distress and quality of life in participants who were undergoing
routine surveillance scan imaging. Among 103 lung cancer patients, 83% reported scanassociated distress before the imaging studies. Bauml et al. also noted that scan distress
was associated with impaired quality of life. Interestingly, the severity of scan-associated
distress was not related to the receipt of the scan results, indicating that scanxiety may
exist well beyond the scan itself; thus, being told “good news” may not be as reassuring
as once assumed (Bauml et al., 2016.).
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Scan-related anxiety may be more prevalent in cancers with known steep,
downward disease trajectories such as pancreatic cancer. Individuals with pancreatic
cancer have the worst prognosis of individuals with any other cancer; they have high
rates of disease recurrence, high symptom burden, and debilitating psychological distress
(Janda et al., 2017; NCCN, 2022; Petzel et al., 2012).
Pancreatic Cancer
Pancreatic ductal adenocarcinoma is the deadliest malignancy and the third
leading cause of cancer-related death in the United States (ACS, 2021b). With an overall
5-year survival rate of 10% across all stages of disease, surgical resection remains the
only curative option and even after surgery, pancreatic cancer will recur in over 75% of
patients (Gordon-Dseagu et al., 2018). For most patients, surgery is not an option.
Pancreatic cancer is most often diagnosed in advanced stages and less than 20% of all
malignancies are surgically resectable at the time of diagnosis. Many factors contribute to
late-stage diagnoses. Because pancreatic cancer has a relatively low incidence, it is not
commonly seen in the primary care setting. As a result, early symptoms which are often
vague and non-specific often go unnoticed by the patient's primary care provider
(Schmidt-Hansen et al., 2016). In addition, there are no screening tests for pancreatic
cancer and any investigation involves diagnostic tests that are expensive and invasive to
the patient. Consequently, patients often undergo multiple office visits and consultations
before a diagnosis can be made (ACS, 2021b; McGuigan et al., 2018).
Psychological Distress in Pancreatic Cancer
Compared with other cancers, psychological distress is much more prevalent in
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pancreatic cancer survivors with nearly 60% of all patients reporting clinically significant
levels of distress at some point throughout their cancer trajectory (Carlson et al., 2018;
Mehnert et al., 2018). The poor prognosis coupled with the high symptom burden has
been reported as a major contributing factor to the higher rates of psychological distress
(Bettison et al., 2018; Pijnappel et al., 2021). Symptoms of anxiety often coexist with
clinical depression and can have a detrimental effect on patient outcomes, including
increased morbidity and mortality and impaired quality of life (Beesley et al., 2016;
Janda et al., 2017; Lewis et al., 2018). In a recent landmark report evaluating the suicide
rates among individuals with newly diagnosed cancers, Saad et al. (2019) reviewed
Surveillance, Epidemiology, and End Results (SEER) data from over 4.6 million patients
within their first year of a cancer diagnosis. Higher rates of suicide were associated with
poorer disease prognoses, and individuals with pancreatic cancer had the highest rate of
suicide when compared with all other cancer sites (Saad et al., 2019). These findings are
consistent with the previously reported cancer suicide literature (Henson et al., 2019), and
underscore the need for frequent distress screening and psychosocial interventions in this
population.
Pancreatic cancer survivors who have undergone curative surgical resection may
be faced with additional fears and worries of cancer recurrence. Although only a few
studies have examined psychological distress in pancreatic cancer patients following
curative resections, high rates of FCR have been reported. Using a cross-sectional design,
Petzel et al. (2012) explored FCR in a sample of 240 pancreatic cancer survivors
following curative pancreatectomy. Despite survivors being on average nearly four years
out from their surgery, more than one-third of the patients suffered high levels of FCR.
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Post-operative fears of recurrence were associated with high levels of anxiety including
frequent fearful thoughts, emotional disturbances, and functional impairments which
negatively impacted quality of life (Petzel et al., 2012). The study findings are
understandable given the high rates of relapse and the high likelihood of death from the
disease. For post-operative survivors the stakes are high. There is currently no effective
treatment for recurrent pancreatic cancer and a recurrence would invariably indicate a
fatal prognosis, with a median survival time of around 9 months (ACS, 2020; Moletta et
al., 2019). Although a recurrence typically occurs within the first two years following
surgery, it may develop as late as seven years post-pancreatectomy (Akabori et al., 2014;
Feng et al., 2019). Consequently, FCR is a significant and realistic concern for this
population and represents a primary source of psychological distress (Bettison et al.,
2018).
Summary
Pancreatic cancer has the highest mortality rate of all other major cancers and is
the third leading cause of cancer-related death in the United States (ACS, 2021b).
Surgical removal of the tumor offers patients a slim chance of cure, yet more than 75% of
patients will develop recurrent, incurable disease generally within the first two years
following surgery. The high likelihood of recurrent pancreatic cancer requires individuals
to undergo frequent CT surveillance scans every three to six months following curative
surgery. These scans can provoke severe and debilitating anxiety and distress, as they
frequently signal the transition from curable to an incurable disease. Very few studies
have examined the psychological impact of surveillance scans in individuals with cancer
and to date, no study has explored the concept in survivors of pancreatic cancer.
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Untreated anxiety and psychological distress are widely known to worsen quality of life
in survivors of cancer, yet the patient experiences during diagnostic phases of
survivorship remain largely unknown.
The exploration of the lived experience of undergoing a CT surveillance scan
following curative pancreatic cancer surgery will remedy the inadequacies in the
literature and advance understanding of the emotional strain and consequences
surveillance scans may have across cancer survivorship. The knowledge gained from this
study informs future research and provides critical information to oncology health
professionals to help create targeted interventions to improve the quality of life of cancer
survivors.
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CHAPTER THREE
METHODS

“About a week out I start getting really nervous. Wondering what it’s going to show. Is
this it? I obsess over the what-ifs. Will this be the [scan] where my luck runs out? Over
and over – I just can’t get it out of my head.” (Leah, p. 11, lines 313 - 316)

The purpose of this study was to illuminate the lived experiences of scanxiety in
survivors of pancreatic cancer who have undergone curative surgical resection.
Hermeneutic phenomenology as applied by Heidegger (1962) provided the philosophical
foundation for this study, and van Manen’s methodological approach (1990) was used to
guide the research process. This chapter provides an overview of the philosophical
framework of phenomenology, the evolution of hermeneutic phenomenological inquiry,
and the application of phenomenology using van Manen’s methodological approach. A
description of the research methodology is provided along with a description of specific
study components including the sample, setting, procedure, data analysis plan, protection
of human subjects, and trustworthiness of the data.
Hermeneutic Phenomenology in Human Science Research
Little is known about the personal experiences of undergoing surveillance scans
following curative pancreatic cancer surgery. For this reason, a qualitative study using a
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hermeneutic phenomenological approach was chosen. Qualitative research provides an
in-depth understanding of phenomena by exploring personal experiences through the lens
of human subjectivity (Munhall, 2012). Phenomenology is a form of qualitative research
that focuses on the study of an individual’s lived experience within the world (Neubauer
et al., 2019). It is an appropriate method to use when attempting to understand the
essence of an experience or phenomenon that is not fully understood (Munhall, 2012;
Richards & Morse, 2013). Hermeneutical phenomenology uncovers meaning within
human subjectivity. In this methodology, knowledge comes into being through language
and interpretation (Van Manen, 1990). Understanding is viewed as an evolving and
dynamic process and through continual reflection, writing, and rewriting, the researcher
may come to interpret and describe the essence or meaning of the lived experience
(Heidegger, 1962).
When conducting hermeneutic phenomenological research, there are diverse
approaches to inquiry, each with its own assumptions, methodologies, and distinct
characteristics to guide the research process (Errasti-Ibarrondo, 2018). The researcher is
responsible for selecting a phenomenological approach that is congruent with their own
worldview, their professional discipline, and the phenomenon under study. For the
purpose of this study, van Manen's methodological approach was used as it combines the
descriptive features of Husserlian's transcendental phenomenology with the interpretative
features of Heidegger's hermeneutic phenomenology to create a blended framework that
regards phenomenology as, "always descriptive, interpretative, linguistic, and
hermeneutic" (van Manen, 2014, p. 26). The use of a hermeneutic phenomenological
approach allowed the researcher to uncover the reality from the cancer survivors'
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perspective so that in-depth, pathic descriptions of the essence of the phenomenon could
be gleaned from the data. The methodology chosen is compatible with the researcher's
personal worldview, is congruent with the phenomenon under study, and is wholly
consistent with the discipline of nursing.
Phenomenology as a Philosophy
Phenomenology is the philosophical study of the structures of consciousness, or
essences of experiences (Husserl, 1931). The term phenomenology is derived from the
Greek "phaenesthai," which means "to appear," and is based on constructivist philosophy
which describes all phenomena as cognitive constructions formulated by the human being
(Kant et al., 2011). In the twentieth century, Edmund Husserl (1859-1938) founded the
philosophical movement of phenomenology as a protest to positivism which was the
dominant philosophical movement of the time (Reiners, 2012). The positivistic paradigm
asserts all knowledge is based upon observed facts and phenomena that are ordered,
rational, and logical. Reality is the same for every person and can be objectively
measured independent of human interaction (Comte, 1856; Reiners, 2012). Although
widely popular, positivism failed to describe essential phenomena of the human world
such as values, feelings, intentions, and the life experiences of human beings. Husserl
rejected the positive approach and attempted to restore the reality of humans in their
lifeworlds or "lived experiences" by introducing a philosophical framework that sought to
uncover the pure essence of a phenomenon (Quotoshi, 2018). Husserl described
phenomena as what appears in the consciousness and asserted the world is knowable only
through cognitive awareness. All one can ever know and understand must present itself to
consciousness, and anything outside of consciousness is unknowable and therefore
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outside the bounds of a lived experience (van Manen, 1990). Husserl adopted the concept
of intentionality which asserted that every act of consciousness (e.g., thinking,
perceiving, remembering) is related to some object and is always intentional. One
becomes aware of something because it intentionally enters their consciousness, and the
goal of phenomenology is to seek the essence of consciousness (Husserl, 1931).
Husserl described essence as the universal quality or qualities that are essential to
the phenomenon and make something what it is. To understand the essence of a
phenomenon one must intentionally bracket all prior knowledge, judgments, and
presuppositions, and objectively describe the phenomenon under study. Bracketing or
phenomenological reduction is a key assumption in Husserlian phenomenology. Only by
intentionally suspending one's preunderstandings can one investigate, describe, and
understand the core components of the phenomenon under study (Husserl, 1931. This
philosophical framework is known as transcendental phenomenology and was eventually
expanded on by Husserl's student and protégé Martin Heidegger (1889 – 1976).
While Husserl developed an eidetic descriptive form of phenomenology,
Heidegger expanded the phenomenological movement by moving beyond description and
giving priority to interpretation. Heidegger believed all knowledge is interpretation and
one’s understanding of the everyday world is derived from one’s own perception of it.
Heidegger developed interpretative phenomenology by incorporating hermeneutics, the
study of interpretation, into his phenomenological approach. In hermeneutic
phenomenology, knowledge comes into being through interpreting and describing human
experience (Polit & Beck, 2017). Whereas descriptive phenomenology focuses on
uncovering the essence of an individual’s lived experience, hermeneutic phenomenology
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focuses on interpreting the meaning an individual gives to their experience. Heidegger
rejected the idea of completely bracketing the subjectivity of the researcher, believing it
impossible to rid the mind of all prior knowledge and preconceived awareness of a
phenomenon. He asserted that prior understandings impact one’s own interpretations of
the world and personal awareness is intrinsic to the hermeneutic phenomenological
approach (Reiners, 2012). Meaning is always interpretative and presupposes prior
understandings. Knowledge comes into being through language, history, culture, and
social practices and it is only through one’s placement in the world or Dasein, that
accurate interpretation and understanding can occur (Heidegger, 1962).
A central theme of hermeneutic phenomenology is the belief that understanding
and interpretation are intertwined in a circular process known as the Hermeneutic Circle.
This process posits that during an interpretative understanding of new knowledge, the
knowledge obtained serves to inform one’s prior knowledge (e.g., presuppositions,
biases, judgments) which in turn presupposes the new knowledge obtained. In
hermeneutic phenomenology, understanding is a continuous revisionary process by which
one’s preconceived knowledge is repeatedly broken down and revised as new knowledge
is obtained. Knowledge development is described as an evolving process and through
continual awareness, reflection, and interpretation one may come to understand the
essence or meaning of the lived experience (Heidegger, 1962).
Phenomenology as a Research Methodology
As a method of inquiry, hermeneutic phenomenology seeks to uncover a
phenomenon as it is experienced subjectively, through the lifeworld or lived experience
of the individual (Munhall, 2012). The researcher does not merely ask, “How do cancer
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survivors prepare for their surveillance scans?” but asks instead, “How do cancer
survivors experience their surveillance scans?" Perceptions originate through an
individual's lifeworld, and it is through the lifeworld that knowledge and understanding
of the world are created. Using this methodology, the consciousness of the individual
experiencing the phenomenon must be explored to understand how life is perceived
through the experience and to discern the meaning the individual attributes to experience.
An individual's perception, interpretation, and meaning of an experience are informed by
their background or unique life experiences which are a culmination of numerous factors
including their social, cultural, historical, and family influences. Human beings are
embodied in their own worlds and only understandable in their own contexts (Richards &
Morse, 2013). The lived experience is the point of arrival and departure in
phenomenological research; transforming the experience into a textual expression of its
essence is the primary research goal (van Manen, 1990).
Max van Manen’s Phenomenology of Practice
Van Manen's (1990) phenomenology of practice is an integrated
phenomenological approach that blends several philosophical sources to create a
descriptive and interpretative method of inquiry that can inform and guide the research
process. For van Manen, phenomenology is fundamentally a writing activity with a
primary goal of creating text that can uncover the essential structures or essences of an
experience (van Manen, 2014). Building on the work of Husserl and Heidegger, van
Manen introduced six methodological themes to guide researchers in conducting
hermeneutic phenomenological research. For this study, van Manen's approach was used
as a framework, and each step is described in detail below.
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Van Manen's Six-Step Research Activities
1. Turning to a phenomenon that seriously interests us and commits us to the world.
The first step requires the researcher to identify a phenomenon of profound
interest and formulate the research question. The phenomenon of interest in this study
was developed through the researcher's clinical experiences caring for individuals with
cancer who were undergoing repeated surveillance scans to monitor for disease
recurrence. This led the researcher to question, "What is it like to endure these scans
every few months?" In caring for patients who had survived poor prognosis cancers with
high rates of recurrence, and in which recurrent disease would invariably indicate a
terminal prognosis, the researcher wondered, "What is it like to survive one of the
deadliest forms of cancer and undergo frequent surveillance scans knowing a cancer
recurrence would mean incurable disease?" Reflection on this question led the researcher
to reflect on survivors of pancreatic cancer, a deadly malignancy with extremely high
rates of recurrence and a mortality rate over 90%. Among those diagnosed, only a very
small minority of patients will be eligible for a potential cure that involves aggressive,
neoadjuvant chemotherapy, followed by an extensive surgical resection and then at least
three additional months of adjuvant chemotherapy. Despite the treatments, more than
75% of patients develop recurrent disease and eventually die from their cancer.
Understanding the trajectory of this disease led the researcher to formulate the research
question.
Van Manen's (1990) first step also requires the researcher to use reflexivity to
explicate their assumptions, preunderstandings, and existing bodies of knowledge that
may predispose the researcher to interpret the nature of the phenomenon before the
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research study. To reduce the subjectivity of the researcher, all prior knowledge,
awareness, and presuppositions of the phenomenon were documented a priori in a
research notebook and continually reflected upon throughout the study.
2. Investigating experience as we live it rather than as we conceptualize it.
The second research activity is the process of gathering experiential data from
participants who have experienced the phenomenon. Data are chiefly obtained by indepth dialogue between the researcher and participant. Van Manen emphasized the
importance of communication between the researcher and participant and conceptualized
the researcher as the instrument through which participants tell their stories. Experiential
data consist primarily of observations and in-depth interviews, but oftentimes other
secondary sources are used to augment understanding. Secondary data sources can
include supplementary texts, artwork, poetry, novels, or other artistic expressions which
add insight and clarity to the phenomenon of interest. The researcher in this study used
in-depth participant interviews as the primary source of data. Additional data from nonscholarly literature, poetry, and artwork were used to contribute to the essential nature of
the participant experiences.
3. Reflecting on essential themes that characterize the phenomenon.
Hermeneutic phenomenological reflection is van Manen's third research process
and involves analyzing the study data and identifying the essential themes which
characterize the phenomenon. Analysis of the data involves immersion in which the
researcher reads through field text numerous times to arrive at an initial interpretation
that can guide the coding process and help to uncover thematic aspects hidden in the
participant's lifeworld descriptions. Using phenomenological reflection, researchers select
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thematic statements and obtain thematic artistic expressions and reflect on the meaning of
the lived experience. Four lifeworld existential themes can be used as guides for
reflection: lived space (spatiality), lived body (corporeality), lived time (temporality), and
lived human relation (relationality). These four existentials pervade the lifeworlds of all
human beings and can be used during thematic analyses to bring different perspectives of
the lived experience. For this study, immersion and thematic analyses were performed
following van Manen's research process. Specific details describing the remaining steps
of data analyses are reported under the Data Analysis section.
4. Describing the phenomenon through the art of writing and rewriting.
The fourth research activity describes the creation of phenomenological text. This
activity is achieved when the researcher begins to organize the essential themes as a way
of describing the experiential meanings of the phenomenon. The text created from
phenomenological inquiry contains meaning in a way that differs from other forms of
text. Phenomenological text evokes emotion and enables the reader to reflect on their
own prior experiences, feelings, perceptions, relationships, and self-image. This type of
text fosters pathic forms of knowledge that cannot be conveyed by any other means.
Some experiences are ineffable or beyond one’s linguistic competency. For example, the
experience of love, which is difficult to describe, may be better reflected in a song or a
painting. These indescribable experiences may be better illustrated through artistic
sources of text such as poetry or anecdotal narratives.
Consistent with the process of the Hermeneutic Circle, data collection and
analysis occur simultaneously as a circular process in which text is read through as a
whole, broken down into smaller parts (codes or themes), then synthesized again as a
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whole. This process occurs repeatedly until a new understanding emerges. In this way,
understanding increases by moving from an understanding of the parts to an
understanding of the whole, and again back to the parts, continually changing as new data
are introduced. Knowledge is an evolving process and through continual reflection,
writing, and rewriting, one may come to uncover the essence or meaning of phenomena.
5. Maintain a strong and oriented relation to the phenomenon.
This research process requires the researcher to remain strongly focused at all
times on the ultimate purpose of the study. Van Manen describes phenomenological
research as a demanding and onerous process in which the researcher can easily lose
interest and indulge in speculation or settle for preconceived opinions of the phenomenon
under study. To be strong and oriented to the phenomenon requires the researcher to
maintain an intense focus on the research question.
6. Balancing the research context by considering the parts as a whole.
The final research activity requires the researcher to remain focused on the
methodological approach by engaging in continuous evaluation of the emerging text as a
whole to ensure all elements of the text are presented. The text should be strong, rich, and
deep, and evoke understandings through language that seems to be non-cognitive and
intuitive in nature. As van Manen notes, the essence of an experience has been adequately
described through language if the description reveals the lived quality and significance of
the experience in a fuller and deeper manner (van Manen, 1990; 2014).
For this research, van Manen’s approach offered a descriptive, reflective,
interpretative, and engaging mode of inquiry from which the essence of experiencing a
pancreatic cancer surveillance scan was elicited.
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Study Design
This qualitative study used a hermeneutic phenomenological methodology to
address the research question, "What is the lived experience of undergoing a pancreatic
cancer surveillance scan following curative surgical resection?" Data were collected
during interviews conducted over 23 months from August 2019 to July 2021. The
research was guided by van Manen's (1990) hermeneutic phenomenological approach.
Setting
This study was conducted in two separate multidisciplinary cancer centers in the
Southeastern United States. All in-person study visits and study-related procedures took
place at one of the two specified study sites. These institutions were chosen as they
receive a high volume of patients with pancreatic cancer -- more than 100 patients
annually. In addition, both institutions employ board-certified medical oncologists,
surgical oncologists, advanced practice oncology nurses, certified oncology nurses,
oncology physician residents and fellows, and social workers specializing in oncology
care.
Sample
The target population for this study was individuals who underwent curative
surgery for pancreatic cancer and were undergoing frequent CT imaging to monitor for
disease recurrence. A purposive criterion sample of 18 survivors of pancreatic cancer was
recruited to participate in this study. Purposive sampling is a qualitative sampling
technique in which researchers select specific participants who may be able to provide
information-rich data to help illuminate the questions under the study (Patton, 1990).
Criterion sampling is a form of purposive sampling in which participant selection is
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based on meeting pre-determined criteria of importance (Moser & Korstjens, 2018).
Eighteen eligible participants were approached in-person by the investigator and given
details about the purpose and procedure of the research study. Each individual was asked
two questions to determine eligibility for the study. The questions were:
•

When you have an upcoming surveillance scan, do you find yourself thinking
about the scan more than twice a day?

•

Are you comfortable sharing your personal experiences with your scans?
All eighteen individuals answered “yes” to both questions and were deemed

eligible to participate. The use of this type of selective sampling procedure allowed the
researcher to decide whether the potential participant could provide rich informative data
that would yield meaningful insight into the study questions (Patton, 1990).
The final determination of the sample size was directed by the emerging analysis
of the data. In qualitative inquiry, data must be collected until theoretical saturation is
achieved. Data saturation is achieved when the information provided by the participants
is rich and thick and is replicated. For this study, the data saturation occurred when the
existing data offered no new insight or direction into the research question. Saturation
provided the researcher with certainty and confidence that the analysis is strong, and the
conclusions are accurate (Richards & Morse, 2013).
Eligibility Criteria
Participants were selected using the following inclusion criteria: (a) age 18 or
older, (b) diagnosed with pancreatic adenocarcinoma, (c) status post curative
pancreatectomy with no radiologic evidence of disease, and (d) undergoing routine CT
imaging at intervals no greater than every six months for disease surveillance. Although
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CT and MRI are the two recommended imaging methods for pancreatic cancer disease
surveillance (NCCN, 2021), previous findings revealed MRI-related anxiety secondary to
patient fears of confinement and claustrophobia-related distress (Heyer et al., 2015; Lo
Re et al., 2016). For this reason, only participants undergoing CT imaging as a primary
method of surveillance were included. Potential participants were excluded if they had:
(a) radiologic evidence of disease recurrence or progression or (b) impaired cognitive
ability that would render them unable to complete the questionnaires.
Procedure
Recruitment
Study recruitment took place in-person, in one of the two designated study sites
and proceeded through the following mechanisms. To identify potential participants, the
researcher electronically reviewed oncology clinic schedules and identified patients with
upcoming medical visits who met the eligibility criteria. Patients who met the eligibility
criteria were approached by the researcher during their routine office visit. After their
medical visit while still in the private exam room, patients were given information about
the study including study purpose, procedure, types of data collected, risks and benefits
of participation, and confidentiality and privacy. Each person was given a copy of the
informed consent (Appendix B) and was allowed adequate time to read through and ask
questions. Individuals who agreed to participate were asked to sign the informed consent
form and were given a copy of their signed form. Prior to giving written consent, the
researcher asked each participant the established criterion sampling questions to
determine suitability for the study. Participants who answered "yes" to both questions
were eligible to participate.
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Data Collection
Primary data sources collected for this study included transcripts and audiotapes
of in-depth semi-structured interviews, the researcher's field notes, analytic memos, and
observations, and baseline demographic data. Secondary data sources included poetry,
art, and literary works. The use of secondary data sources such as art, literature, theatre,
photography, poetry, or other aesthetic works is congruent with hermeneutic
phenomenological inquiry as they have the potential to further illuminate the essence of
the phenomenon under study (Munhall, 2012; van Manen, 1990). In choosing appropriate
artistic sources of data, the researcher explored a variety of literary websites and
databases and examined countless sources of visual and literary artworks in the forms of
paintings, sketches, photographs, film, poetry, novels, internet blog sites, and cancer
support groups. All secondary data sources were chosen for their relevance to the
emerging themes and their ability to further illustrate the essence of the phenomenon.
Baseline demographic data for each participant were collected by the investigator
through a review of the participant's medical chart. Demographic data were collected on a
case report form (see Appendix C) and included name, age, gender, date of diagnosis,
cancer staging, date of surgery, date of most recent scan, and any comorbid conditions.
Upon enrollment in the study, participants were given the option of either an inperson or telephone interview. Interviews were scheduled for a time most convenient for
the participant. Interviews took place over 23 months, in one session; each interview
lasted between 60 – 90 minutes. Initial interviews were conducted using a semistructured guide which was developed from the review of the literature. Additional
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follow-up interviews were initially considered; however, changes in participant disease
status limited the opportunity for follow-up interviews.
Interview Guide
Interviews were informal and conversational allowing each participant to tell their
story in their own way. An interview guide (see Appendix D) was used and consisted of
open-ended questions with the ability for follow-up probes. The preliminary interview
questions included: Can you tell me what it’s like to have a diagnosis of pancreatic
cancer? What is it like to receive the date of your next scheduled CT scan? Can you
describe the days leading up to your scan? How do you experience the wait time before
you get the results? This type of reflective interviewing is common in qualitative inquiry
as it provides the researcher with general overview questions and allows deeper
exploration of relevant issues (Munhall, 2012).
The interviews were audio-recorded and transcribed verbatim by the researcher.
Field notes were taken by the researcher throughout each interview and included the
researcher's observations of details such as the participant's body language, non-verbal
cues such as gaze, gesture, and action, and their emotional response to questions.
Following each interview analytic notes were created to record the researcher's reflective
thoughts about the interview, including initial impressions, interpretations, speculations,
preliminary codes, and emerging themes.
Data Analysis
Data were analyzed continuously throughout the duration of the study to allow for
emerging analysis of the data (Corbin & Strauss, 1990). After each participant interview,
the researcher transcribed the audio recorded interview and read through it several times
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in its entirety to understand the whole account of the experience. Following van Manen's
methodological approach, dynamic thematic data analysis was performed which included
reflexive reading and writing and re-writing of the data to identify relevant concepts and
phrases threaded throughout each interview. Each line of text was read and reflected upon
to identify recurring statements or phrases that seemed to reflect essential components of
the experience. Next, the researcher created preliminary units of meaning which seemed
to characterize the phenomenon and categorized them separately in an Excel worksheet.
Grouped meaning units from each interview were then compiled in an aggregated
worksheet and regrouped to search for any concept linkages or connections between
emerging themes (see Appendix E). Thematic descriptions were also gleaned from nonscholarly literature, artwork, poetry, and the researcher's field notes and compiled
together with thematic statements from the interviews so that groupings were inclusive of
the full data set. Thematic statements were then analyzed individually and compared with
each transcribed interview as a whole to check for consistency in emerging themes and to
identify the essence of each theme. Categories of meaning units, preliminary codes, and
the final themes chosen were reflected upon as a whole to ensure textual meaning was
accurately reflected in the context of the experience. This required the researcher to
critically review themes while maintaining focus on the study design and central aim of
the study. In hermeneutic phenomenology, this process ensures themes are not only
descriptive in nature but are also interpretative in that they reflect the underlying meaning
and true essence of the experience (Heidegger, 1962).
Once essential themes and meanings were established, a final stage of analysis
was performed in which final themes were reflected upon using van Manen's (1990) four
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existentials of lived space, lived body, lived time, and lived relation. These four
fundamental existentials form the underlying structure in which human beings experience
their lifeworlds. During this stage, secondary sources of data in the forms of poetry and
artwork were used to symbolize the final themes and to provide the reader with an
alternative understanding of the scanxiety experience. This final step of analysis provided
the researcher with an additional process of phenomenological writing and re-writing and
helped to enhance the researcher's understanding of the existential lived experience of the
phenomenon.
Trustworthiness
Trustworthiness in qualitative research can be determined from the researcher's
ability to account for the specific processes which lead to the outcomes of the study
(Richards & Morse, 2013). Using criteria established by Lincoln and Guba (1985),
several strategies were used to ensure methodological rigor and trustworthiness of the
research findings. Lincoln and Guba suggested the following four criteria are needed to
establish rigor in qualitative research: credibility, dependability, confirmability, and
transferability. These four criteria were established to mirror the positivists' criteria of
internal validity, reliability, objectivity, and external validity, respectively. Since its
development, the Lincoln and Guba framework has been used extensively as a
benchmark to ensure rigor during the conduct of qualitative research (Richards & Morse,
2013). Each of these four criteria was used in this study and is described in detail below.
Credibility refers to the accurate and truthful depiction of the participant’s lived
experience and the confidence in the truth of the study findings. To ensure study findings
were credible, member checking, prolonged engagement, and persistent observation were
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used. Member checking is a qualitative technique used to establish the accuracy and
truthfulness of the data. Throughout each interview, participants were asked to clarify,
elaborate, and expand on their experiences. As initial themes began to emerge,
participants were asked to reflect on each theme to ensure the emerging data analysis was
congruent with the participant’s lived experience. Prolonged engagement and persistent
observation are highly interdependent methods and refer to the researcher spending
sufficient time in the field, culture, or social setting to thoroughly observe the
phenomenon in order to identify what is relevant to the study. Both as a registered nurse
and as an advanced practice nurse, the researcher has spent nearly two decades in
outpatient cancer care settings working with cancer survivors during times of their
surveillance scans. Throughout the study, she continued to work in the oncology
healthcare clinic where diagnostic imaging was performed and where scan results were
communicated to patients. Although she did not enroll any of her own patients for this
study, she is very familiar with the study setting, the social and cultural context, and the
patient population.
Triangulation was also used to establish credibility and involved using multiple
sources of data to reduce bias and augment understanding. For this study, data were
collected through participant interviews and observations, the researcher's field notes and
analytic memos, social media sources, and online cancer blogs in which patients candidly
discussed their feelings regarding their upcoming scans. Quantitative data measuring
levels of anxiety and fear of cancer recurrence in pancreatic cancer survivors was
collected in a separate study by the researcher and findings were used to provide an
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additional data source to further establish credibility and enhance understanding of the
phenomenon (Winebrenner, 2022).
Dependability refers to the reliability of data over time and in other contexts. In
this study, all raw data, audio recordings, written transcripts, analytic memos, and coding
notes were maintained to create a clear audit trail of study findings. In addition, an
external audit was conducted by an independent nurse researcher on data from the first
nine participants. The independent researcher was able to review the process and study
findings and confirm that the researcher's thematic analyses were supported by the data.
Transferability is a form of external validity and refers to the potential for
findings to be applicable in other settings or groups. This can be achieved by providing
sufficient details and descriptions of data so that others can evaluate the applicability to
other contexts. Thick, rich, and meaningful descriptions of data were used to document
the lived experiences of each participant. Specific details about study settings, eligibility
criteria, sample characteristics, and data collection and analysis methods were provided
so the reader can evaluate the extent to which findings are transferable to other
populations.
Confirmability refers to the objectivity of the researcher and is concerned with
establishing that the findings and interpretations are clearly derived from the data
(Nowell et al., 2017). Lincoln and Guba (1985) state that confirmability is established
when credibility, transferability, and dependability are all achieved. In addition to
establishing these three criteria, the researcher kept a reflective notebook to demonstrate
the research process and how study interpretations and conclusions were made. The
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researcher also maintained self-awareness during the study by continuously reflecting on
prior knowledge, perceptions, and presuppositions throughout data analysis.
Protection of Human Subjects
This study was approved by the University of Louisville Biomedical Institutional
Review Board. No study-related procedures were performed prior to institutional
approval.
Ethical Conduct of the Study
The proposed study was conducted according to the standards of ethical conduct
in research outlined in the Belmont Report (National Commission for the Protection of
Human Subjects of Biomedical and Behavioral Research, 1978). The main ethical
principles of the Belmont Report include beneficence, respect for persons, and justice.
These principles were considered throughout the conduct of the study and specific
protections taken are described below.
Beneficence
Beneficence imposes a duty on researchers to minimize harm and maximize
benefits (DHHS, 1979). In psychosocial oncology trials, research participants are often
asked to complete multi-item questionnaires that may contain sensitive questions and
may be burdensome for a fatigued patient receiving cancer treatments (Dellson et al.,
2018). This study used lengthy interviews with sensitive questions which could have
potentially caused harm to the study participants. All attempts were made to minimize
harm to study participants. In an effort to reduce participant burden and minimize
distress, participants selected the time and place for each interview. Participants were be
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informed of their right to decline participation at any time and refuse any questions which
may increase discomfort or distress.
Respect for persons
"Respect for persons requires that subjects, to the degree which they are capable,
be given the opportunity to choose what shall or shall not happen to them" (DHHS,
1979). This principle is firmly implemented when a comprehensive informed consent
process is completed. The informed consent process was conducted by the investigator in
a private exam room. Before informed consent was sought, the investigator gave specific
details about the nature of the study and explained the risks and benefits of participation.
All potential participants were provided with an IRB-approved consent form that
described the nature of the study and provide sufficient information to make an informed
decision about participation. Participants were informed that their participation was
voluntary and that declining to participate would not impact their care in any way.
Written informed consent was obtained before conducting any research activities and all
participants met eligibility criteria. While there were no conflicts of interest to be
disclosed, participants were informed of their right to be notified of any conflicts of
interest if any arose during the study.
Justice
In human subjects research, justice refers to a participant’s right to fair treatment
and privacy (Polit & Beck, 2017). Several key measures were used to protect
participants’ privacy and anonymity. Subject transcripts and case report forms did not
contain any identifying information. Upon enrollment, all participants were assigned a
unique subject identifier beginning with “001”. The unique identifier helped de-identify
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participant data and maintain participant anonymity. Only research team members had
access to the data which included transcripts, case report forms, and participants’
demographic information were stored in a securely locked file cabinet at the University
of Louisville School of Nursing. The office containing the study materials was always
locked and only the researcher had access. All electronic materials used to transcribe or
store data were secured on a password-protected computer on a University of Louisville
shared and encrypted drive.
Minority and Children Participation
Participation of Minorities
Historically, minorities are underrepresented in healthcare research (Erves et al.,
2017). Pancreatic carcinoma is a cancer that affects men and women from all racial and
ethnic groups. Participants from all racial and ethnic groups were eligible if they met the
eligibility criteria. This study used two distinct study sites to increase the potential for
ethnic diversity in the sample. Every attempt was made to enroll representative
proportions of minorities in this study.
Participation of Children
The occurrence of primary pancreatic cancer of any histology in persons less than
18 years of age is extremely rare (Gordon-Dseagu et al., 2018). In consideration of this,
children were not included in this study.
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CHAPTER FOUR
FINDINGS

"My life is broken up into three-month increments, living scan-to-scan. This last scan was
good so I can breathe a sigh of relief, but there's another one coming. So, it's hard to
appreciate the good results of today when you know the next one could kill you." (Luke,
p. 14, lines 282 – 285).

The purpose of this study was to illuminate the lived experiences of scanxiety in
survivors of pancreatic cancer who have undergone curative surgical resection.
The participants provided vivid, in-depth descriptions of their experiences. Two essential
themes emerged from the data: the recurrent cycle of scanxiety and the hope for lifelong
remission.
Sample Characteristics
Eighteen survivors of pancreatic cancer participated in this study. Interviews took
place from July 2019 through May 2021 and were either in-person or by phone, lasting
from 45 to 120 minutes. All participants were Caucasian and non-Latino; ten females and
eight males composed the study sample. Participant ages ranged from 51 to 73 years;
their mean age was 63.7 years of age (SD = 6.3). All 18 participants had undergone
curative surgical resection of pancreatic adenocarcinoma; the median time since surgical
resection was 17.5 months. Most of the participants (61.1%) had received neoadjuvant
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chemotherapy and every participant received adjuvant chemotherapy, although two
participants had to discontinue treatment early due to poor tolerance to therapy. The
overall cancer stage of participants was determined following surgical resection and
ranged from stage IA to III. At the time of data analysis, five participants (27.8%) had
died of disease (DOD), three participants (16.7%) had developed progression of disease
(POD) and were either receiving palliative treatments or under hospice care, and 10
participants (55.6%) had no evidence of disease (NED). Table 1 displays additional
characteristics of the study sample.
Participant Characteristics
Table 2 displays the characteristics of each participant. At the time of each
interview, participants had undergone curative surgical resection of their pancreatic
cancer, were in complete remission from their cancer, and had recently received
computed tomography (CT) scan results revealing no evidence of recurrent disease.
Interviews took place either in-person in the oncologist's office after the participant
received their scan results or by phone within two days of the participant receiving their
scan results. Pseudonyms were assigned to protect the identity of each participant. A brief
description of each participant is provided to describe background information and the
historical context of each participant's lifeworld.
Anne was a 72-year-old retired school teacher with stage IIB pancreatic cancer
who underwent surgery eight months before her interview. Anne's interview took place
by phone one day after she received her scan results.
Naomi was a 57-year-old homemaker with stage III pancreatic cancer who
underwent surgery 10 months prior to her interview. Naomi was interviewed in-person at
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Table 1
Sociodemographic Characteristics of the Study Sample (N = 18)
Characteristics
Gender
Male
Female
Race
Non-Hispanic White
Marital Status
Married living with spouse
Widowed
Divorced
Separated
Education
High school diploma
College graduate
Stage of pancreatic cancer
Stage IA
Stage IIA
Stage IIB
Stage III
Neoadjuvant chemotherapy?
Yes
No
Adjuvant chemotherapy?
Yes
Yes, but discontinued early
Time interval between scans
Every 3 months
Every 6 months
Annually

n (%)
8 (44.4)
10 (56.6)
18 (100.0)
12 (66.7)
1 (5.6)
4 (22.2)
1 (5.6)
9 (50.0)
9 (50.0)
3 (16.7)
3 (16.7)
4 (22.2)
8 (44.4)
11 (61.1)
7 (38.9)
16 (88.9)
2 (11.1)
16 (88.8)
1 (5.6)
1 (5.6)
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Table 2
Characteristics of the Participants (N = 18)
Assigned
Pseudonym

Gender

Age

Stage of
Cancer

Time since
Surgery
(months)

Current
Status

Anne

F

72

IIB

19

DOD

Naomi

F

57

III

10

DOD

Hannah

F

51

IIA

75

NED

Mike

M

65

III

5

POD

Deborah

F

62

IIA

7

NED

Miriam

F

56

IIA

16

NED

Mark

M

69

IIB

9

DOD

Steve

M

63

IIB

17

DOD

Luke

M

68

III

11

POD

Jake

M

69

III

39

POD

Tom

M

57

III

8

DOD

Sarah

F

58

III

18

NED

Ruth

F

58

III

18

NED

Matt

M

68

IIB

16

NED

Ethan

M

73

III

21

NED

Paula

F

64

IA

35

NED

Carolyn

F

66

IA

33

NED

Leah

F

70

IA

18

NED

Note. DOD = died of disease; NED = no evidence of disease; POD = progression of
disease.
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her oncologist's office after she received her scan results. She was accompanied by her
husband.
Hannah was a 51-year-old registered nurse who underwent surgery for a stage
IIA pancreatic cancer six years prior to her interview. She was interviewed by phone two
days after she received her scan results.
Mike was a 65-year-old repairman who underwent surgical resection of stage III
pancreatic cancer six months prior to his interview. He was interviewed in-person in his
oncologist's office shortly after receiving his scan results. He was accompanied by his
wife.
Deborah was a 62-year-old college admissions officer who underwent surgical
resection for a stage IIA pancreatic cancer seven months prior to the interview. She was
interviewed by phone one day after receiving her scan results.
Miriam was a 56-year-old administrative assistant who underwent surgery for
stage IIA pancreatic cancer 16 months prior to her interview. She was interviewed by
phone one day after she received her scan results.
Mark was a 69-year-old cattle farmer who underwent surgical resection for a
stage IIB pancreatic cancer nine months prior to his interview. He was interviewed in
person in his oncologist’s office after he received his scan results. He was accompanied
by his wife and adult daughter.
Steve was a 63-year-old corporate executive who underwent surgery for stage IIB
pancreatic cancer 17 months before the interview. He was interviewed by phone two days
after he received his scan results.
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Luke was a 68-year-old retired physician who underwent surgery for stage III
pancreatic cancer 11 months prior to his interview. He was interviewed by phone one day
after he received his scan results.
Jake was a 69-year-old owner of a trucking company who underwent surgical
resection for stage III pancreatic cancer three years prior to his interview. His interview
took place in person in the oncologist’s office after he received his scan results. He was
accompanied by his sister.
Tom was a 57-year-old auto mechanic and car enthusiast who underwent surgery
for stage III pancreatic cancer six months prior to his interview. Tom was interviewed by
phone one day after receiving his scan results.
Sarah was a 58-year-old retired insurance adjuster who underwent surgery for
stage III pancreatic cancer 14 months prior to her interview. Sarah was interviewed by
phone two days after receiving her scan results.
Ruth was a 58-year-old retired administrative assistant who underwent surgery
for stage III pancreatic cancer 14 months prior to her interview. She was interviewed by
phone one day after receiving her scan results.
Matt was a 68-year-old financial analyst who underwent surgical resection for
stage IIB pancreatic cancer eight months prior to his interview. He was interviewed by
phone two days after receiving his scan results.
Ethan was a 73-year-old retired army veteran who underwent surgical resection
for stage IIB pancreatic cancer two years prior to his interview. Ethan’s phone interview
was conducted one day after he received his scan results.
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Paula was a 64-year-old female who underwent surgical resection for stage IA
pancreatic cancer three years prior to her interview. She was interviewed by phone two
days after receiving her scan results.
Carolyn was a 64-year-old oncology nurse who underwent surgical resection for
stage IA pancreatic cancer 22 months prior to her interview. Her interview took place by
phone two days after she received her scan results.
Leah was a 70-year-old editor who underwent surgical resection for a stage IA
pancreatic cancer eight months prior to her interview. Leah’s interview was by phone two
days after she received her scan results.
Summary
Each study participant was in complete radiologic remission from pancreatic
cancer and underwent at least one surveillance CT scan to determine if recurrent disease
was present. All participants were interviewed within two days of receipt of their CT
scan. In the remainder of this chapter, the essential themes of the phenomenon of
undergoing surveillance scans after curative pancreatic cancer surgery are discussed.
Research Findings
The phenomenological analysis of 18 interviews revealed two essential themes:
the recurring cycle of scanxiety and hope for lifelong remission. The recurring cycle of
scanxiety describes the complex sequence of events survivors experienced during the
time surrounding their surveillance scans. Hope for lifelong remission describes the
distinct hope and belief that lasting remission is possible. The uncovering of these themes
reveals the essential meaning structure and true essence of pancreatic cancer survivors’
lived experience of undergoing surveillance scans. Table 3 describes the essential themes
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and subthemes uncovered in the data. In the following sections, each essential theme and
corresponding subthemes are defined and discussed. Illustrative quotes from participants
are offered to support the existence of the themes.
The Recurring Cycle of Scanxiety
The first theme is the recurring cycle of scanxiety which is a complex repetitive
pattern of behavioral and emotional responses manifested by pancreatic cancer survivors
during the time surrounding their surveillance scans. Scanxiety or scan-related anxiety
describes the anxiety and distress before, during, and after a cancer-related scan. The
cycle of scanxiety identifies the universal experiences participants described in the time
interval starting from the days leading up to the scan and following the receipt of the scan
result. This essential theme is composed of five overlapping subthemes: the fear of cancer
recurrence, mental preparation, proof of life, waiting to exhale, and resetting the clock.
The Fear of Cancer Recurrence
Regardless of participant demographics, cancer stage, or age of survivorship,
every participant experienced a persistent and underlying fear of cancer recurrence. This
was described as a deep-seated permanent fixture in the lives of participants and was
described by several survivors as being "always in the back of my mind." During nonscan times, recurrence fears were generally manageable, and although negative thoughts
could "creep in" at any time, survivors were able to suspend their fears and continue
performing their normal daily activities. Upon notification of an upcoming scan, or
generally about one week prior to the scan, participants experienced a heightened fear of
cancer recurrence that increased in strength and magnitude as the scan date approached.
The words used to describe the emotion included "worry," "fear," "dread," "scared,"
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Table 3
Essential Themes and Subthemes of the Lived Experience of Scanxiety
Theme and Description

Subthemes

Recurring cycle of scanxiety
A complex repetitive pattern of behavioral
and emotional responses manifested by
survivors during the time surrounding their
surveillance scans.

Fear of cancer recurrence
Mental preparation
Proof of life
Waiting to exhale
Resetting the clock

Hope for lifelong remission
Balancing fatalism and optimism

The intense desire for a complete recovery
and a return to normal life.

Reframing hope

"frightened," and "terrified." Fears of recurrence took the form of daily recurring and
intrusive thoughts of the cancer returning, interpretation of unrelated body symptoms as a
sign of recurrence, and an inability to plan for the future. One participant described a
panic-type fear of recurrence that induced a post-traumatic stress response causing her to
flashback to her original cancer diagnosis. Heightened cancer fears caused significant
psychological distress including disturbances in mood, sleep, and daily functioning. The
upcoming scan served as an external trigger, an approaching reminder of the looming
threat to life. Matt described how his fear of cancer recurrence increased in the days prior
to the scan.
I'm on a three-month schedule for scans so for probably two months
before the scan I'm doing ok. I mean I'm always thinking about the cancer
coming back. It's always there in the back of my mind but I'm not dwelling
on it. And then maybe one week to 10 days before the scan, [the
oncologist's office] will call me with the [scan] date and from that point,
48

I'll be thinking about it pretty much every day. I mean constantly. I can't
put it out of my mind. It's just wondering what it's going to show and if
[the cancer has] come back. I'll watch the calendar and mark off the days,
beforehand. As the date gets closer, I get more tense, and by the time it's
here, well let's just say I'm wound pretty tight (p. 3, lines 69-81).
The date of the approaching scan created a foreboding sense of unease, which
prompted several participants to unintentionally lock the scan date into their working
memory. Naomi described how her upcoming scan date was imprinted in her mind.
As soon as it gets scheduled, I put it in my phone and just dwell on it. The
date is in my brain constantly. It gets locked in my brain. It’s always there
just like looming over me. And I’m always looking at the calendar and
doing the countdown (p. 1, lines 27-29).
As fears of cancer recurrence increased in the days leading up to the scan, the
participants experienced physical and psychological manifestations which affected their
daily lives. Psychological manifestations included mood changes such as depression,
anxiety, irritability, feelings of powerlessness and dread, fatigue, daily ruminations of
death and dying, fear of being a burden to one's family, and impaired memory and
concentration. Physical manifestations of recurrence fears involved increased pain,
disruptions in the gastrointestinal system, and disorders in sleep.
Psychological Manifestations. Intolerance for uncertainty was described by
nearly every participant (16/18). The high likelihood of recurrent disease was made
known to the participants by their medical oncologists, leaving many to wonder how a
disease recurrence would impact their survival status. A majority (14/18) assumed

49

recurrent disease was not curable and this awareness heightened fears of recurrence and
generated a growing sense of powerlessness. The belief that cancer could recur at any
time was among the most difficult concepts for the participants to accept. The seemingly
arbitrary nature of a cancer recurrence frustrated the participants who wanted to retake
some control of their lives. The participants had endured aggressive chemotherapies and
a difficult surgical resection to achieve full remission of their cancer. The idea that cancer
could return randomly, at any time without warning, left the participants feeling
vulnerable and defenseless. Anne described the sense of powerlessness she experienced
during times of her surveillance scans.
It’s hard knowing there’s nothing you can do to change it or make it
better. Especially after all that. You get through the chemo and the
Whipple and then they give you more chemo and it makes you so sick.
But you do it, everything they throw at you – you do. And you get through
it all. And now you have to wait to see if anything comes back. And
there’s nothing you can do. There’s nothing that improves your odds. You
just have to wait (p. 1, lines 38-44).
Miriam vividly described the feeling of powerlessness using a metaphor to help
the researcher better understand her perspective.
I know there’s nothing I can do to affect the outcome. I don’t have any
control over any of it. It’s kinda like a feeling of free fall with no idea if
there’s a net down there to catch you (p. 5, lines 186-189).
Survivors who described themselves as having a high internal locus of control
appeared to have the most difficulty tolerating uncertainty. Leah described herself as a
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“control freak” and someone who took responsibility for her life and her circumstances.
She described her struggle in coping with the uncertainty.
I think it’s so hard for me because I need to feel in control. I have to feel
like I am contributing to the decision in this. And it’s very frustrating to
know that you cannot control it. I can do certain things. I can follow a
treatment plan. I can get surgery. But other than that, there’s really nothing
I can do. And that is probably the hardest aspect of this (p. 16, lines 637645).
The increased feeling of powerlessness was accompanied by the dread of having
to undergo the scan. The anticipation of the upcoming scan was one of the most difficult
features of the scan period. Anticipating the scan often involved an endless series of
negative thoughts, focused on the worst possible outcomes. Several participants described
their feelings of powerlessness and dread vividly using analogies to help the researcher
understand.
Once I get the [scan] paperwork in the mail, it’s all right there in my mind.
And from that point forward it’s always there gnawing in my mind. It
doesn’t completely incapacitate me or anything, but it’s something that
you would be in a group somewhere with friends, having a good laugh or
something, and then it would hit you, “Oh shit. I got to go do that on
Monday.” It gives you a little gut check or something. So yeah, it gnaws at
you. It's like waiting to go in front of a judge that has a sentence for you.
Somebody’s making a decision that’s going to affect your life forever. It’s

51

a feeling that your life is completely out of your hands (Jake, p. 7, lines
288-306).
The feeling of not being in control is something that's always in the
back of my mind. Sometimes it doesn't dominate as much but it seems like
when you get closer to having the scan done you feel it more. And then
just thinking of having to have the scan, it's like, ugh, I gotta take a test.
And you're thinking, I wonder how well I'm going to do on my test? Let's
hurry and get it over with. Can the teacher hurry up and grade it right
away and give me back my results?! Sort of like that, I guess (Luke, p. 5,
lines 163-174).
It's kind of like going to the dentist. You know you have to do it.
It's not the doctor making you do it, but you have to do it for yourself to
make sure that you're okay. And as that time gets shorter, you just dread it.
You hate it. Just the thought of having it done and that [the cancer] could
come back. And then your whole life would change (Miriam, p. 3, lines
100-110).
The feelings of dread provoked by an upcoming scan were not associated with the
scan itself. The participants considered scans a normal part of cancer care and a majority
reported a sense of familiarity with the scan procedure, as most had undergone numerous
CT scans throughout their survivorship period. The dread provoked by the upcoming
scan was primarily associated with the potential consequences of a positive scan result
indicating a cancer recurrence. Participants acknowledged their understanding of the
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serious nature of a pancreatic cancer recurrence, and this awareness heightened fears of
recurrence and generated fears of death.
It’s not the scan. I mean I’ve had several scans at the hospital so that
doesn’t bother me. It’s the results. I’m afraid of the results. If the cancer
came back, I mean I wish someone would just tell me that it’s not
inevitable that I’m going to die. Which I mean I’m smart enough to know
that that’s probably what’s going to happen (Anne, p. 5, lines 181-187).
Steve was accustomed to having a working plan for circumstances in his
professional life. Since his diagnosis, he struggled to cope with the uncertainty of his
pancreatic cancer and believed if he was given the strategy for managing a recurrence,
this might alleviate some of his fears.
The scan is not bad. I mean it’s not my first rodeo so I don’t have any
concerns about that. I think I worry about the dying part. I mean nobody
has ever talked to me at any level about what would come next. You know
‘If it comes back, we'll try this’ or ‘If it comes back, we'll do this’. It’s just
out there. And I think that would help me. Just knowing what the next
steps would be (p. 4, lines 168-175).
Steve was only one of four survivors who preferred to know the treatment
strategy for a cancer recurrence. Most participants (11/18) assumed recurrent disease
would be fatal and actually preferred uncertainty or "not knowing" how the disease would
be managed, rather than the certainty of knowing their fate in the context of an incurable
disease.
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In the days before an upcoming scan, mood changes were reported by 15 out of
18 participants. Irritability was described by six participants and occurred primarily
among the females (5/6). Depression, anxiety, isolation, fatigue, and impaired
concentration also were reported. Naomi described how her mood changes affected her
husband. "Right before [my scans] I get hateful. I do, I get bitchy, I lose sleep. I take it
out on him a lot (pointing to husband). Especially the weekend before. It's really rough on
him." (p. 6, lines 250-254).
Similar experiences were described by other survivors. Hannah, who was six
years out from her pancreatic surgery at the time of her interview, recalled her scan
experiences the first two years after her surgery. She experienced debilitating symptoms
in the week leading up to her scan.
For that whole week before the scan, I was a mess. And it got worse the
closer it got to the scan date. I couldn't sleep. I had trouble focusing and
concentrating on things. I couldn't work. I mean I'd go to work but I wasn't
really doing anything. I just couldn't get out of my own head. It was really
hard on my family. The kids just knew to keep their distance (p. 1, lines
16-22).
Sleep disturbance (15/18) was one of the most commonly reported manifestations
experienced by the participants as they anticipated their upcoming scan. Leah described
her inability to sleep on the eve of her CT scan.
The night before [the scan] I’m wired. Making sure everything is out and
ready. I’m kind of OC there. Just making sure everything is nice and
arranged. And I think, ‘OK I’m going to go to bed early.’ And then I lay
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there wide awake. And then you start doing the countdown, ‘If I go to
sleep now, I can get 4 hours of sleep. If I go to sleep now, then I can still
get 2 hours.’ And I keep doing this until it’s time to get up (p. 9, lines 386394).
Physical Manifestations. About half of the participants (8/18) described an
increased incidence of somatic symptoms in the days leading up to their scan. Symptoms
such as diarrhea, nausea, abdominal pain, and incisional discomfort were commonly
reported and perceived by the participants as a possible sign of cancer recurrence.
Deborah described how her physical symptoms affected her anxiety about her scans.
I can usually manage my anxiety pretty well. I try not to get too worked up
but this last [scan] I had was different. I had these weird symptoms about
two days before the scan. I started feeling weak, my blood sugars were
running high, and I just didn’t feel good. I got sort of depressed. I’d never
felt like this before and I figured this was some new cancer symptom
presenting itself (p. 1, lines 38-46).
Five participants recognized their physical symptoms were psychosomatic in
nature, primarily because symptoms consistently appeared in the days leading up to the
scan. Miriam described the “mind games” her body played on her when a scan date was
approaching. Although she recognized symptoms were likely anxiety-provoked, she still
experienced exacerbated fears and anxieties of cancer recurrence.
Once you get scheduled for the scan then that’s when your mind just starts
playing games with you. You know you don't feel good, and this bothers
you or that bothers you, or maybe you have diarrhea, or you know, kind of
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all of the above. And I think it's really just that your mind is playing
games with you. You’re thinking, ‘Oh, you're going to have this cat scan
and they're going to find something’ (p. 1, lines 23-32).
Luke experienced physical symptoms of abdominal pain near the site of his
surgical incision. He recalled how the pain induced a flashback to the time of his original
diagnosis.
Yesterday [the day before the scan] I started to feel a little discomfort over
here in my abdomen. And I thought, ‘Uh oh, what is this? What's going on
here? Is this something else?’ It takes me back to when I got diagnosed.
Maybe it's not the same type of symptoms but just a little discomfort. And
it makes you wonder if the cancer's back (p. 12, lines 441- 463).
Although only half (8/16) of the survivors experienced physical symptoms in the
days leading up to the scan, every participant experienced some type of psychological
change. It was important for survivors to continue to do their normal everyday activities
despite their psychological impairments. More than two-thirds of the participants (13/18)
described separating their emotions from their actions to perform their normal daily
routines. Jake described how he used compartmentalization to cope in the week leading
up to his last scan.
I don't know if my routine changed. I mean on the outside I still went to
Kroger and got the car washed but those are just outside functions. The
inside functions were bad. I don't want to say I was having a pity party
inside, but I may have been a little woe is me. Externally my routines were
pretty much the same, but internally I'm balled up inside. It's inside me. It
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gives me perspective when those scans come up. I realize that it may not
be so important to get my shoes shined or whatever, you know? But I keep
everything inside. I just tell people at work I have a doctor's appointment.
I don't tell them all what's going on (p. 8, lines 310- 323).
Fear of cancer recurrence is the primary source of scan-related anxiety and the
antecedent to the cycle of scanxiety. Fluctuating recurrence fears drive each phase of the
cycle and shape the emotional and behavioral responses survivors manifest throughout
their scan period.
Mental Preparation
Mental preparation for a cancer surveillance scan is a highly complex and
emotional process for which survivors must ready themselves for their upcoming scan.
This is the first phase in the recurrent cycle of scanxiety and begins one to two weeks
before the upcoming scan. As fears of cancer recurrence increased, the participants
needed to prepare themselves for all possible outcomes of the scan, while also continuing
to function in their normal daily life. The participants used two simultaneous coping
processes to prepare themselves for the scan: contingency planning and distraction.
Contingency Planning. Contingency planning is a profoundly emotional and
distressing process requiring participants to deeply reflect upon worst-case scenarios in
the days leading up to their cancer scan. It was important for participants to conceive the
impact recurrent disease would have on those around them and contemplate alternative
plans if a recurrence was identified on their upcoming scan. Planning for contingencies
allowed the participants to gain some control over their life and mitigate the damage a
cancer recurrence would have on those around them. Fifteen participants described a
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process of envisioning the possibility of a cancer recurrence. Each reflected on how
recurrent cancer would impact their lives and the lives of others and created introspective
interim plans to prepare for all possibilities. Ruth took care of her young grandchildren
during the day while her daughter-in-law worked. She worried about the care of her
grandchildren and who could take her place if cancer returned.
My mind just starts thinking, what if I do have cancer? And my daughterin-law is still working. So, what will we do now? Who is going to be there
during the day to watch the grandkids? You know, how can we adjust
things so it’s not too disruptive for [the grandkids]? So, I just try to think it
through and make plans in my head, just in case (p. 7, lines 282 – 288).
Miriam and her husband had full custody of her three grandchildren. As the
primary caregiver in the home, Miriam worried how a recurrence would impact the
family. She described the difficulty of making backup plans when she is unsure how a
cancer recurrence would be managed.
I start thinking about what would happen if [the cancer] came back. How
we would handle it, you know as a family? Who’s going to get the kids off
to school? And then what about pick-up? And homework? I mean all of
these things. These are things we need to prepare for. And it’s hard
because I don’t really know what would happen [if the cancer recurred].
If it comes back in my pancreas, I mean would they still be able to take it
out? Would I go back through and do all the chemo treatments? Or will I
do radiation? I mean just exactly what would happen? And I mean if I did
all that stuff am I still just going to die? And again, who would take care
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of the kids? I mean I guess it's just all that [rolled] into one (p. 8, lines 344
– 351).
Contingency planning for a cancer recurrence was an inner-directed, thoughtful
process. Participants did not record or document alternative plans nor did they seek
support or assistance from others. The introspective process was a mental reflection of
possible strategies that could be used to mitigate the family life disruptions a cancer
recurrence would produce. Paula’s contingency planning consisted of identifying bills
that would need to be paid and considering alternative caregivers for her mother.
I try to think about what I’d do if it comes back. If everybody’s going to
be able to find everything they need. Would they be able to do this, or
would they know where to pay this? And I take care of my mom, she lives
with me. What would happen to her, you know? (p. 7, lines 248 – 253).
Planning for contingencies often involved delaying major decisions or postponing
plans until after the participant received their scan result. As a mother with young
children, Hannah described the difficulty making future plans before her upcoming scan.
I always have to look ahead at what’s going on in the weeks after my scan
and I say to myself, ‘Oh my gosh, if my cancer comes back, I can't do this,
or this, or this.’ Because I'll be back in treatment. So, for me, I can never
plan for the future. I can never plan vacations. I can never volunteer to go
on my daughter's field trip in a month. I can't contribute to anything
because I don't know if I'll be dead or if I’ll be in treatment (p. 1, lines 2429).
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Contingency planning was distressing and tightly intertwined with rising fears of
cancer recurrence. Although anxiety often increased during times of planning, three
survivors described increased feelings of control and a sense of fulfilling their obligations
to others, which in turn lessened uncertainty and generated some peace of mind. Steve,
63, was asked to describe how planning for contingencies impacted his scan-related fears.
I'm not sure it affects it at all. I mean it doesn't take [the anxiety] away
that's for sure. It's still there. But I think it helps to know we have
something in place. And that everyone would be all right and know how to
manage. And then knowing that I could do that for [my wife]. She doesn't
need to worry about all of that (p. 3, lines 111 – 115).
Distractions. Planning for contingencies required participants to acknowledge the
high likelihood of incurable disease and to confront the serious threat to survival that
faced them. Prolonged ruminations of death were common and emotionally taxing to
patients in the week leading up to their scan. Participants often found ways to temporarily
dismiss negative thoughts with various distraction techniques. Distractions allowed the
participant to mitigate the threat of the upcoming scan to continue normal routines,
maintain social relationships, and participate in daily activities. Nearly every participant
(16/18) reported some form of distraction as a way of coping with their upcoming scan.
Distraction techniques were primarily in the form of staying active and keeping busy.
Mike described how he kept his mind occupied.
I like to stay pretty busy just to keep my mind occupied. Like this morning
[before my scan] I went down to the bank, came home, watered some
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flowers, was just looking for things to do. Just to stay busy (p. 12, lines
494 – 497).
Ruth also looked for tasks around the house to keep herself from thinking about
her upcoming scan.
I have to keep really busy. For this last [scan], I knew [my anxiety] was
going to be bad, so this weekend I volunteered to sell raffle tickets for our
bike club and I kept really busy. And then I came home and got my
shower and got ready and cooked dinner for my husband. Monday was a
little awkward because I was home alone, so I cleaned the house and that
occupied my time. I did the laundry. I vacuumed. I gave my dogs a bath. I
found things to do. I was able to occupy my time this weekend because I
knew what was coming. And that helped (p. 10, lines 397 – 406).
Luke acknowledged the emotional burden of trying to think through worst-case
scenarios for extended periods. He described alternating his contingency planning with
distraction techniques.
I have to plan all scenarios, try to figure out what I would do if the scan
doesn’t go my way. How the family would handle everything. When I
start to think about it too much, I get down a little. My wife will say to me,
“I know you’re getting this way because we’re getting ready to go for a
scan.” And I’m just thinking about all the options. But you can only do
that for so long. Then I have to go out and actually do something, you
know? So, I go out and walk. Because if I were to sit at home in a chair all
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day, well I’m sure I would dwell on that. And being active really helps
keep my mind occupied (p. 4, lines 47 – 158).
Every distraction technique reported involved the use of physical or mental
activities to redirect threatening thoughts and decrease awareness of the upcoming scan.
Hannah described an alternative method of distraction involving the use of medication to
induce sleep when she was unable to effectively distract herself from thinking about her
scan.
I try to avoid all idle time about 1 week before my scan. I can’t watch TV
because I can’t concentrate. I just need to be active and when I’m not busy
doing something then I just want to sleep. I still have some Phenergan left
over so I’ll take that or something just to let me sleep. I mean I’d prefer to
stay busy but when I can’t then I’ll take some pills and take a nap. I never
want to have idle time. Just so I don't think about it (p. 1, lines 34 – 40).
Distractions helped temporarily lessen fears of cancer recurrence, although not all
distraction techniques were successful. Many attempts of distraction were impeded by
triggering events that redirected the participants’ thoughts back to their cancer and
subsequently back to thoughts of their upcoming scan. These triggers included receiving
notifications from cancer providers, watching television shows or movies about someone
with cancer, seeing cancer-related social media postings, watching television
commercials about cancer-directed therapies, and attending funerals. Fearful thoughts of
upcoming scans triggered by these events were described as insidious in nature, subtly
“creeping” into the participant’s conscious mind and dismantling the peace of
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unawareness. Sarah described the impact television commercials had in the days leading
up to her scan.
I really try not to think about [the upcoming scan] but so many times it
just creeps in. My mind wanders or I’ll see a commercial about a certain
chemotherapy for lung cancer and then it makes me think, ‘Do I have that?
Has the cancer spread to my lungs?’ (p. 10, lines 411 – 414).
Over one-third (7/18) of the participants identified the television show Jeopardy
with host Alex Trebek as a trigger for fear of cancer recurrence. These participants
avoided the show during the time surrounding their surveillance scans. Although
Jeopardy! was one of Matt’s favorite television programs, he described his emotional
reaction to the show.
I know this sounds strange, but I can’t watch Jeopardy before [my scan].
And it’s one of my favorite shows. I just don't want to see Alex Trebek. I
just don't want to see him and then knowing what he went through. It just
makes me think about it more than I already am (p. 7, lines 290 – 293).
Waiting to Exhale
In the cycle of scanxiety, the second phase is "waiting to exhale" and describes
the participants' experiences in the interval of time between the scan procedure and
receipt of the scan result. This period was the most difficult juncture for many
participants and elicited the highest levels of anxiety and distress. Most participants
(15/18) reported fears of cancer recurrence were at their highest point immediately before
receiving the results of their scan. Factors influencing participants' perception of the scan
result experience were affected by numerous external stimuli including the length of time
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waiting for the result, the method of scan result notification, social relationships, and the
perceived congruence between members of the multidisciplinary care team. Both the
patient-provider relationship and the duration of the waiting period were important
variables influencing how the participants experienced their scan results. Most of the
participants (15/18) received their scan results in person, in their oncologist's office,
although three learned of their results by self-viewing the report from the patient portal,
My Chart.
The Wait. The length of time between the scan procedure and receipt of the result
was identified by every participant (18/18) as the single most important factor influencing
fears of recurrence and distress. Participants preferred to receive their scan results in
person, from their medical or surgical oncologist, and within one to two days of the scan
procedure. Several participants reported same-day or next-day scan results which
provided comfort and helped lessen uncertainty and fears of recurrence. Luke described
the effects of shortened waiting periods.
I usually get the scan in the morning and see the doctor right after. So, I
always know I’ll find out the results within hours. That really helps. If I
had to wait more than a day or two, well that would be horrible. That
uncertainty. You know your mind will take over. And for me, I just want
to know. If I had to wait longer it would make my anxiety so much worse
(p. 2, lines 55 – 60).
Three participants experienced an extended wait time of at least one week
between their scan and receipt of the results. The negative psychological impact of the
prolonged wait time was described and identified as a key factor in exacerbating anxiety
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symptoms. Miriam described an increase in psychosomatic symptoms during the week
between her scan procedure and receipt of the scan result.
I had to wait a full week [to get the results] this time. It was horrible. I felt
sick the whole week. My incision bothered me, I felt sick to my stomach. I
just didn’t feel good. And then finally going in [to the oncologist’s office]
to get the results. My blood pressure was way up, and they mentioned that
to me. Then they take you back to that little room, and that’s when it really
gets bad. In my head I’m like, ‘Come on, come on’ and it could only be
like 10 minutes until Dr. X comes in, but you feel like it’s been 30 or 40
minutes since you’ve been back there. You can’t see him soon enough to
be told what the results are (p. 4, lines 140 – 145).
Three participants who frequently experienced prolonged wait times described a
bimodal distribution of scanxiety that peaked before the scan procedure and again before
receiving the results. Sarah described her experience with bimodal scanxiety.
About a week before the scan is when my anxiety really gets started. It
gets really high right before the scan, but then goes down a little because
the scans are over with. But then you have to wait another week and you
think, 'Okay well now what?' and my anxiety starts to go back up, and by
the time you go to the doctor that anxiety has come back and is probably
one of the worst times (p. 7, lines 158 – 163).
Increased waiting times often occurred on the day the survivor received their scan
results. Several participants experienced unanticipated delays in the clinic setting while
waiting for the provider to give them their results. Although delays are not uncommon in
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healthcare settings, the unexpected delays exacerbated symptoms of anxiety, and in some
participants, caused significant psychological distress. Jake described his experience
when his oncologist was running late during clinic.
Waiting for the results, that's when I'm most anxious. Sitting in that room
waiting for the doctor to come in. And this last time Dr. X was running
late. I think he was called into surgery or something, so I had to wait
longer than usual. It was after 2:00 and I'd been up since 4:00 am for my
scan, and I hadn't eaten anything. But at that point, I couldn't eat anyway.
My stomach was churning like a milk truck just waiting for him to come
into the room. I almost got sick right there in the room. I mean you’re
waiting for the news to find out what the rest of your life is going to be
like (p. 6, lines 246 – 258).
Ruth described how she showed up at her oncologist's office to receive the scan
results, but her scan report was not ready. She had to wait in the doctor's office for nearly
90 minutes until the results were available.
It was hard. Just sitting in [the oncologist’s] office in one of those little
rooms. I tried to keep calm, but it was really hard. My husband was with
me. I finally told him I was going to close my eyes for a little bit, and I
rested my head on his shoulder. And I closed my eyes for a little while and
just waited. It seemed like forever. And [the office staff] told me I didn’t
have to wait, and they’d call me with the result, but I didn’t want to leave.
I just wanted to get it over with (p. 12, lines 452 – 464).
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Carolyn experienced an unexpected delay receiving her scan results and assumed
the delay was related to a cancer recurrence. She described her catastrophizing thoughts
of recurrent disease and her emotional reaction to her oncologist who appeared
indifferent to her angst.
For this last scan, I felt like I had to wait longer for the doctor to come in
and give me the results. I sat there in the office and kept fidgeting. I was
praying, 'Oh my God, Please God let it be clear, let it be clear. And it was
getting later, and he still hadn't come. And I thought, "Oh my God. My
scans are not okay. And that's why they haven't come into the room yet.
Because they're dreading coming into the room to tell me. And when (the
oncologist) finally came in the room, he just started chit-chatting about
random things. And I was like, "Are my scans okay?" And he goes," Oh
yeah they're clear. They're fine" And I said, "Well that needs to be the first
thing you tell me because I'm a wreck!" (p. 7, lines 234 – 242).
Time since Diagnosis. Most participants (16/18) described stable scan-related
fears of cancer recurrence, with scan-related anxiety that had not changed in frequency or
intensity since their pancreatic cancer surgery. Two participants, however, reported a
decrease in their scan-related fears over time. Hannah, who was six years post-surgery,
and Carolyn, who was nearly three years post-surgery, both reported a notable decrease
in levels of anxiety as time passed. Hannah described the impact of time on her scanxiety.
For the first two years, it was awful. I'd have so much anxiety before [my
scans]. Then probably about three years after my diagnosis, I sort of
relaxed a little bit before my scan. This is when I realized, 'Hey, I might
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not die from this right away'. So then, I became a little more relaxed with a
little more time under my belt. And at my four-year mark, I had this kind
of inner peace come over me with my scans. I still got nervous and had
trouble sleeping. Even now, I always get worried and still take something
the night before my scan to help me sleep, but I just didn't worry as much.
After four years the scan stopped being in the forefront of my mind. I
mean, I always knew it was there, and I was waiting for my results, but at
least I could function (p. 2, lines 67 – 80).
Notification Method. During the study, federal legislation was passed which
altered the way in which participants received their scan results. The 21st Century Cures
Act (2020) is a federal law requiring health care organizations to provide patients with
immediate and unfettered access to their electronic health information, thereby
eliminating wait times for test results and allowing patients to receive their entire medical
record, including office notes and scan reports in real-time, often before their health care
provider has viewed them. This legislation was enacted after 11 participants had
completed their interviews. Prior to this policy change, participants received their scan
results in-person, from their oncologist. The in-person method occasionally involved
prolonged wait times which influenced and exacerbated scanxiety symptoms. Seven
participant interviews occurred after the passage of this law. Although all seven
participants were eligible to view their results online, only three participants regularly
used their My Chart account and received text notifications of available scan results.
Upon receiving the notification, all three participants chose to view their scan results
using the patient portal. The participants described heightened recurrence fears similar to
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fears described by participants receiving in-person scan results; however, the selfviewing participants reported different experiences in the way they prepared themselves
for their results. For example, when receiving in-person results, most participants (15/18)
preferred to have someone accompany them to their oncologist’s office. The support
person predominately chosen by married participants was a spouse. Unmarried
participants chose close friends to accompany them. Interestingly, when using a patient
portal, all three participants preferred to view their scan results alone, isolated from
family and friends. The self-viewing participants did not tell anyone of their available
scan results, describing a need to view their results at their own pace. Leah explained her
experience viewing her results online. “I was alone, and I actually prefer that. I need to
have time to process my feelings before sharing them with anybody.”
Overall, patient portals were viewed as both positive and negative. Although a
majority of participants (15/18) did not use the patient portal in place of receiving inperson scan results from their oncologist, numerous participants (11/18) appreciated
having the option to use the portal to reduce scan-result wait time, if they could not
receive their scan results in a timely manner. Matt described the temptation of receiving
immediate scan results using the patient portal.
Ugh… My Chart is the devil. But I hate the waiting time between the scan
and getting the results, so whenever I get the text [notification of scan
result], I have to pull it up. There are times when I’m afraid to look at it
but it’s hard not to once you get that text. And this last time, I actually saw
the result before Dr. X and Dr. Y saw it. So, I already knew the result was
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good news. Thank God. Because I don’t like doing that. I really don’t like
to see the results until I’ve seen the doctor (p. 1, lines 27 – 31).
The appeal of using the patient portal enabled participants to gain immediate
access to their scan results to reduce uncertainty. As an oncology nurse, Carolyn
recognized the emotional risk associated with accessing potentially devastating results
without an oncology provider present.
My anxiety has actually been getting better as time has gone on. But now
[the hospital] has passed some new law or regulation where they release
all your scans in My Chart. So now you can see the scans even before you
see the doctor. And that freaks me out. So, like I got the text message that
I had a new result and I'm like, Oh my God. Do I look at it? Do I not look
at it? I don't know what to do. What if I look at it and it's not okay? And
then I've got to sit here and wait a day or two before I see the doctor. And
I ended up opening it up and looking at it. And thank God it was ok. But
what if it wasn’t? (p. 10, lines 402 – 414).
Social Support. During times of an upcoming scan, several participants (8/18)
avoided discussing their scan-related worries and fears of recurrence with family and
friends. Limiting these emotional conversations was an important method of coping in
the days leading up to the scan and allowed participants to control triggering discussions
that could increase scan-related anxiety. An unsolicited conversation about the upcoming
scan had the potential to antagonize recurrence fears, provoking further anxiety and
distress. For example, two participants described the counterproductive effect of a wellintentioned spouse or coworker who initiated scan conversations to allay fears but instead
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disrupted the distraction techniques survivors had put in place. It was important for
survivors to control the negative intrusive thoughts as much as possible. Paula chose not
to discuss her upcoming scans with her husband or her mother.
I don't tell anyone [of upcoming scan] because there's nothing they can do.
And just talking about it makes me feel worse. This is mine to deal with.
And it's not like they can say anything to make it better. My husband
would just want to talk about it and I don't want to talk about it. That's the
last thing I want to do (p. 4, lines 224- 227).
Social support was an important factor mitigating the participants’ anxiety when
receiving in-person scan results. As described earlier, most participants preferred to have
someone accompany them to their oncologist’s office to receive the news. Social support
was not as important to participants who viewed their results using the patient portal, as
all three participants preferred to view their results alone and isolated from others.
Patient-Provider Relationships. The patient-physician relationship was
described by nearly all participants (16/18) as an important factor influencing the severity
of scan-related anxiety. Survivors acknowledged the importance of perceiving their
oncologists as highly skilled and competent. All 16 participants believed their oncologists
were well-equipped to handle recurrent disease and this lessened their fears of their
cancer returning. Ethan described his relationship with his medical and surgical
oncologist and how these relationships impact his scan-related anxiety.
I just feel like I'm in the best hands. I feel like Dr. X is the best surgeon
and I think Dr. Y has been really impressive. They’re both tried and
proven. Everyone has told me how great they both are. And they both
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have a good trusting relationship and that keeps my anxiety in check (p.
10, lines 363 – 372).
As a physician, Luke had the resources to travel outside his home state to obtain
his medical care from one of the largest cancer centers in the country. After several
recommendations, he eventually decided to use a local surgical oncologist because of his
confidence in the skill of the surgeon. He described the importance of trusting his
provider and how this affected his emotional reaction to his upcoming scan.
I'm grateful that I was able to find Dr. X because in the beginning, we
were like, where do I go? Do I go to Johns Hopkins? Do I go to MD
Anderson? And we were setting up all of these things. And then several
colleagues helped me realize that we have one of the best surgeons here in
Louisville with Dr. X. I have 100% confidence in him. And so yeah, I still
get anxious [around scan times] but just having him on my team brings me
comfort (p.16, lines 611 – 618).
Incongruence among Providers. The participants were followed by both their
medical oncologist and surgical oncologist, and most (17/18) had separate provider visits
to discuss their scan results. It was important for participants to view both oncology
providers as a cohesive partnership, working together for the patient’s best interests. Of
the 18 participants, nearly three-fourths (13/18) perceived some form of disconnect
between their medical oncologist and surgical oncologist. Provider discrepancies
included poor communication between providers (e.g., lack of sharing medical records)
provider disagreements over treatment plans or conflicting advice from providers. The
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incongruences increased the participants' uncertainty of care and often left patients
feeling "stuck in the middle" and uncertain about whose advice to follow.
Provider disagreements over treatment plans were frequent sources of scanrelated distress. Several survivors witnessed instances in which one provider raised doubt
about another provider’s plan of care. Anne described the disconnect she perceived
between members of her oncology care team.
I’m not sure my two doctors are always on the same page. They disagreed
over when I should start chemo [after surgery], then they disagreed over
when I should stop. Dr. X wanted me to have another cycle but Dr. Y said
I didn't need that much. So, I only got three cycles instead of four. And I
don't think that made Dr. Y very happy. So, I don’t know what to think. I
already have high anxiety from being ill and this makes it so much worse.
I just wish there was better communication (p. 9, lines 376 – 387).
Survivors described instances in which they interpreted casual, even offhand
provider inquiries as evidence their oncology team members were not in communication
with one another. These perceptions increased patient uncertainty and exacerbated fears
of cancer recurrence. Matt described the anxiety he experienced when he was asked about
another provider’s opinion of his recent scans. Matt’s angst was further increased when
he was asked to serve as an intermediary between his medical oncologist and surgical
oncologist.
I don’t know if Dr. X and Dr. Y talk to each other about my treatments.
Dr. Y is always asking me what Dr. X thinks about my scans. And this last
time Dr. X asked if Dr. Y was planning to give me more chemo. I mean
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don't they talk to each other? So now I'm supposed to ask Dr. Y about the
chemo. It's nerve-racking to think that I'm playing the go-between. I don't
have any medical training or knowledge. It's scary to be in that position (p.
3, lines 114 – 120).
Mike also experienced a significant increase in fear when one provider questioned
the other provider’s plan of care.
I think they should be able to communicate with one another. Even
through email or whatever just so everyone's on the same page. I don't
think Dr. X thinks Dr. Y gave me strong enough chemo to make sure it
won’t come back. I mean Dr. X told me I needed the stronger stuff like I
had before surgery, but Dr. Y only offered me the pill. And don’t get me
wrong, I liked taking the pill instead of having that pump on all the time.
But does that mean the cancer’s going to come back because we didn’t do
the pump? So that makes me more nervous with my CAT scan because
I’m thinking I didn’t get the right stuff so now it’s going to come back. I
just wished they would’ve talked to each other (p. 2, lines 76-81).
Discrepancies also occurred when two providers required different types of scans.
For example, every participant underwent a CT scan of the abdomen and pelvis as part of
their surveillance plan. Three participants described the medical oncologist’s additional
need for a CT of the chest which was not always performed when the surgical oncologist
ordered the scan. This resulted in the participant having to undergo an additional CT scan
of the chest which often spawned an additional cycle of scanxiety.
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There’s a level of disconnect between Dr. X’s office and Dr. Y’s office.
With this last scan, Dr. X scheduled me to have a scan of my abdomen and
pancreas area. After I had the scan, I went to see Dr. Y who wanted to
know why they didn’t scan my lungs, too. Well, I don’t know. I don’t
schedule the scans. I guess Dr. X isn’t worried about what’s going on in
my lungs. So now I have to go in next week for another scan of my lungs
and it’s a whole other procedure. I guess it’s not really a big deal but it’s
inconvenient. And now I have something else to worry about (p. 10, lines
404 – 414).
One participant experienced increased distress when her provider misinterpreted
the results of her scan. Sarah described an embarrassing experience when she received
negative scan results from one provider and significantly different results from her other
provider.
Dr. X (medical oncologist) ordered the scan but I had an
appointment with Dr. Y (surgeon) the next day and he was able to pull up
my results. So, Dr. Y came in the room smiling and he said, “You’re
good!” and I’m like, “Really? Are you sure? Because Dr. X had thought
he saw something in my lung on the last scan.” And Dr. Y told me, “No,
everything looks great. Go live a good life. You’re good!” And I was so
relieved. I was crying when I left [his office]. And I came home and
posted on Facebook how surprised I was that [the lung lesion] had
disappeared. And that if you’ve ever prayed for me thank you because I
got this great news from my surgeon. But when I went to see Dr. X the
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next day, he told me it wasn’t a good scan and the spot on my lung had
actually grown. So that was hard to hear. I just wish I hadn’t posted all of
that. I felt embarrassed that I posted how great my scan was because it
wasn’t good news at all (p. 19, lines 804 – 821).
Although Sarah’s scan showed a slight increase in the size of her pulmonary
nodule, the lesion remained too small for biopsy, and disease progression could not be
confirmed. At the time of the interview, Sarah was still considered to be in full radiologic
remission of her pancreatic cancer. Sarah told the researcher, “I’m in limbo. We don’t
know what [the lung nodule] is. But I know it’s too little to biopsy and too small to show
up on a PET scan. So, I just have to have patience and wait for the next scan and see if
anything shows up. And there’s a lot more anxiety with that.” (p. 9, lines 370- 373).
Proof of Life
Except for Sarah, every participant received a negative scan result indicating no
evidence of recurrent disease. The receipt of “good news” was a pivot point in the cycle
of scanxiety and the phase in which participants experienced reassurance and a
significant drop in scan-related anxiety. This third phase of the scanxiety cycle is the
anxiety nadir and was labeled "proof of life" to describe the underlying meaning
pancreatic cancer survivors assigned to their scans. In hostage situations, a proof of life is
a form of communication provided by the hostage-taker as indisputable evidence the
kidnapped victim is alive. Often in the form of photographs or videos, proof of life
evidence is typically the first indication of the condition of the victim and provides
reassurance and hope to the victims' families by reducing the uncertainty of their loved
one's fate (Giebels et al., 2005; Rossin et al., 2018). For study participants, the
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surveillance scans offered a radiologic proof of life, indisputable evidence that survivors
were still “okay” and in complete remission. The proof of life evidenced by the negative
scan provided a permission slip of sorts for participants to resume some aspects of their
normal life. Although no physical changes had occurred, numerous participants (9/18)
described feeling strong and healthy after receiving negative scan results. They were able
to resume their normal roles in the family and in work. They could attend upcoming
family functions and holidays and start to make plans for future events. The negative scan
reduced the uncertainty of the participants’ fate and allowed them to hold on to hope,
despite the high likelihood of recurrent disease. Ruth was interviewed one day after
receiving her scan result and described the overwhelming joy she experienced after
hearing she was still in remission. She became tearful as she tried to put her feelings into
words:
It’s just a wonderful feeling that I want to cry. I want to cry every time. I
made it through another scan. And I can sit here and cry right now. And
I’m sorry (voice cracking, crying softly) I apologize. I made it through
another scan. Nothing showed up. My blood work was superb. I feel
healthy. I don’t feel like a little weakling anymore (p. 12, lines 483 – 490).
Resetting the Clock
The feelings of relief and reassurance following receipt of a negative scan were
ubiquitous across all participants; however, the reassuring effect of the scan result was
often short-lived. The final phase “resetting the clock” describes the temporary
reassurance the negative scan provided and uncovers the participants’ experience living
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with uncertainty during non-scan times. This final stage completes the recurrent cycle of
scanxiety and serves as a pivotal juncture for the cycle to start again.
Temporary Reassurances. The lasting effects of reassurance from a negative
scan varied widely among participants. A minority of participants (4/18) accepted their
scan as evidence of ongoing remission and were able to keep underlying fears of
recurrence in check until the next scan date approached. However, for most survivors
(14/18), the comfort of receiving a negative scan was quickly overshadowed by the
continuous uncertainty of the disease and the ongoing need for future scans. Survivors
described how their “good news” was quickly eclipsed by the need to restart the
countdown to their next scan. Anne described the momentary relief she experienced after
receiving the results of her negative scan.
The scan that I just had came back and they didn’t see any cancer cells. I
mean that's a tremendous relief. But the closer that it gets to the next 3
months, then the greater the anxiety. The clock just starts all over again
(p.1, lines 46 – 54).
Matt described a similar experience.
So even though I got good news from the scans, It's still always in the
back of your head, what if there’s something there they didn't see. Or what
if it's going to come back 3 months from now? It's always in the back of
your mind (p.8, lines 312 – 318).
Several participants expressed uncertainty over the radiologist’s ability to
accurately interpret the scan and detect a possible cancer recurrence. Naomi was
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interviewed in her oncologist’s office less than one hour after receiving her “good news”
scan results. Despite the scan showing no evidence of cancer, she continued to doubt.
I mean even now, Dr. X just told me everything looks great. I’m doing
great. But there’s still a little bit of anxiety thinking, did they read it
correctly? Are they going to call me back later with something they
missed? (p. 5, lines 188 – 192).
All three participants who worked in health care reported a lack of confidence in
the medical technology used to detect a cancer recurrence. As a physician, Luke
understood the limitations of computed tomography.
And what’s always in the back of my mind is that I realize the scans are
not definitive. I mean in order to detect something at that resolution, well
there’s only a certain size in millimeters before you can even detect it. So
that is always there. And it only takes one cell to make trouble (p. 9, lines
323 – 327).
Uncertainty During Non-Scan Times. Living with the uncertainty of a cancer
diagnosis was a pervasive and distressing feeling discussed by every participant. During
times outside of the surveillance scan period, the ruminating and intrusive fears of cancer
recurrence were less frequent. Although underlying fears of recurrence persisted, a
majority of participants (14/18) were able to temporarily dismiss worries and continue
performing their normal daily activities. Leah described her fears of cancer recurrence in
the months following a negative cancer scan.
The fear is still there, but not to the degree as it was previously. It's not an
everyday thinking about it and dwelling about it event. It may pop up in
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my head, but for the first couple of months [after a good scan] it’s easy to
push it back down and say, damnit [Leah], get on with living your life (p.
18, lines 723 – 734).
Participants described a dependence on their surveillance scans and recognized
the unintentional focal point scans had become in their lives. One participant described
her scan as being “the root of my being.” Another phrase, “living scan to scan” was
described by several participants (6/18) as living a life in a constant state of uncertainty.
Carolyn described her life as existing in 3-month increments to reflect the interval of time
between her surveillance scans.
Whenever I get a good scan report, I’m relieved. And I guess I’m okay for
a bit. It’s kind of like you live in blocks of time that are three or four
months long. It's like okay, I can relax for about two and a half months.
And then my anxiety starts building again (p. 4, lines 214 – 218).
Living with the uncertainty of a life-threatening illness was described as a life
priority for Luke. He recognized the need to change his outlook to accommodate the
uncertainty in his life. He described a deliberate form of self-transformation as he
transitioned from physician to patient.
Yeah. I get that relief. But then like I said, I look into the future and think,
okay what's next? What’s the next scan going to show? For now, I’m just
living scan to scan, you know? It’s good that the report was good, but it’s
still always in the back of your mind. It’s not ever going to go away. It’s
like a friend of mine said, “This is your new job.” And he was right. I
mean I was a doctor, but now I’m on the other side. And this is my new
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job. Now I just have to take the time and realize this is my job to do (p. 15,
lines 570 – 579).
Most participants (16/18) envisioned ongoing fears of cancer recurrence for the
rest of their lives. Jake owned and operated a successful business and could not envision
a day when his fear and anxiety over a cancer recurrence would end. He recognized how
cancer had changed him and acknowledged he is not the same person he was before his
cancer diagnosis.
I mean my anxiety gets really high, and after I hear the negative results, it
goes way down but it never goes away. And I don’t think it will ever go
away. I think I’ll always live with anxiety now. I’m never going to be
what I was before my cancer. The best I can do is find a level where I can
operate at my best in the face of my anxiety (p. 6, lines 220 – 224).
Resetting the clock after a cancer scan describes the short-lived peace of mind a
negative scan produces and the instinctive apprehension and dread of the next upcoming
scan.
Every participant described a process of sequential phases of emotional and
behavioral responses during times of their cancer scans. A recurring cycle of scanxiety
consisting of four phases was identified: mental preparation, waiting to exhale, proof of
life, and resetting the clock. Fear of cancer recurrence was the primary source of
scanxiety and was the impetus shaping the survivor’s responses through each phase of the
cycle. The cycle of scanxiety was experienced as a deeply personal and at times painful
process. The essential quality of this experience can be illuminated further using the
language of poetry (see Figure 1).
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Figure 1
Poetry Depicting the Essence of the Theme Recurring Cycle of Scanxiety

Scanxiety
My nights before scans are disrupted by
Ruminations over shattered plans
In fret-filled dreams I am uncomfortable
Inside the machine, positioned with arms extended
In graceless symbolic submission
To unrelieved apprehension and
Vulnerable to verdicts of strangers
Who will scrutinize the geography of my fate
They search for worrisome blots
That highlight unwinding time
But do not show the dread of uncertainty
As images illuminate but fracture solace
By foreshadowing future loss
Peer past the films to see me
Unable to thwart the scanning strife
But still glimmering with hope
(Portman, 2018)

The Essence of Scanxiety Depicted in Poetry
Some phenomenological experiences are so emotionally powerful they are
considered ineffable, or too great for words. In phenomenological research, alternative
sources of expression including fine arts, music, poetry, and cinematography are often
used to illuminate the true essence of the phenomenon being described (van Manen,
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1990). In depicting the essential quality of the scanxiety experience, the true essence can
be further illuminated using the language of poetry. The poem, Scanxiety (Portman,
2018), uncovers the lived quality of the experience in a fuller and deeper manner.
Hope for Lifelong Remission
Hope for lifelong remission is the second essential theme uncovered, and it
describes the underlying hope survivors maintained despite the high likelihood of
recurrent, incurable disease. The word "hope" was used by every participant and was
endorsed as the belief that a cure for pancreatic cancer was possible. Hope was inherent
and central in each participant's narrative. The primary object of hope was to live cancerfree and regain some aspects of life before cancer. The phrase, "I just want my life back"
was used by two participants and supported in several participants' narratives. A
secondary object of hope involved the hope for scan-related anxieties to lessen over time.
Survivors generally assumed anxiety surrounding cancer scans would be a permanent
fixture in their lives yet continued to hope their scans would get easier in the future.
When asked if she believed her scan-related anxiety would get better over time, Sarah
expressed doubt.
Interviewer: Do you think your anxiety concerning your scans will lessen
over time?
Sarah: (Long pause with an audible sigh) Probably not. I mean I've already
had like four of them and it hasn't gotten better. So, I doubt it. But I hope
so. I really do. I hope this gets better because I don't like this feeling. Just
always feeling like something’s wrong when it’s really not. I don’t want to
keep going on like this (p. 12, lines 507 – 512).
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Hope was used intuitively as a form of coping, and lessened fears of cancer
recurrence during times of surveillance scans. Other secondary objects of hope included
the hope to avoid further treatments, to live pain-free, and to reduce the distressing side
effects from chemotherapy and surgery such as diarrhea, nausea, and dyspepsia.
Balancing Fatalism and Optimism
Participants hoped for a full recovery from cancer, but many were cautious to
endorse this goal, acknowledging the notion of not wanting to "tempt fate." The belief
that a full recovery was possible in the face of a pancreatic cancer diagnosis was a
difficult concept to accept. Many participants tried to remain hopeful while balancing
their fatalistic views of the disease. Leah found it difficult to find hope considering the
high likelihood of recurrent disease. She had performed an extensive online search
examining the statistics of pancreatic cancer and found discouraging results. She
described trying to offset her fatalistic view of pancreatic cancer with an optimistic
outlook in which she could live out her life cancer-free. She frequently had to remind
herself to live in the moment and not in a future state.
You have to be realistic. You have people who want to deal with things
directly and others who want to bury their heads in the sand. I like to
confront things head-on. So, what I have to do is balance being a realist
with kicking myself in the butt. I have to remind myself, keep on - you're
not dead yet! You know like Monte Python? (laughing) You're not dead
yet! (p. 18, lines 767 – 784).
Hope for lifelong remission was at the heart of the cancer scan experience and
provided the means that made it possible for survivors to continue on the recurring cycle
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of scanxiety. The belief that a cure was possible was often unspoken yet corroborated
throughout each participant’s story. Hope was the center of the scanxiety cycle, and all
things revolved around hope. When Luke was asked to summarize his overall scan
experience, he made the focus of hope explicit in his response.
It’s hanging on to hope. That’s what I keep thinking. Just hang on to that
hope that one day this will all be behind you. I’ve made it one year, and
that’s great, but we need to get further down the road. I ran into a friend
the other day. He’d gone through some leukemia treatments, and he was
like 12 or 13 years in remission. And I was like wow, wouldn't I like to
say that? (p. 15, lines 584 – 590).
Reframing Hope. The time surrounding a surveillance scan was described by
many (12/18) as a way to prioritize what matters most. The typical daily stressors of life
seemed trivial to those facing a life-threatening disease. One participant described the
scan period as a time to “retake stock of your life” and figure out what really matters. As
perspectives shifted, survivorship goals were often revised. Several participants (6/18)
described an adaptive process of reframing hope in relation to the ongoing uncertainty of
cancer survivorship. Ruth was interviewed 18 months after her pancreatic cancer surgery.
Although she desperately wanted to live as long as she could, she learned to hope in new
ways that allowed her to confront the uncertainty facing her. She described a process of
reframing hope, from an initial desire for long-term survival to the hope of surviving to
live one more day. Ruth learned to appreciate every day as a gift and live life in the
present. She described the importance of not sweating the small stuff, a sentiment she
reinforced with a sign on her front porch.
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I think I've already reached my hope stage. Just to be here. When I first
heard the words pancreatic cancer, I thought it was a death sentence because I never heard of anyone surviving. And I did. So, I think my hope
is already here. And I think I've been blessed. It's a blessing to be here. It's
a blessing to be around my family. To watch my grandkids graduate. I
watched my oldest grandson graduate in Florida last week, and it was the
best thing in the world. I watched my granddaughter win a mathematics
award, and it was great to be there. And that's what I'm thankful for. And
if I'm not here tomorrow well that's ok. Because I'm here today (p. 19,
lines 855 – 863).
The Essence of Hope Depicted in Art
Maintaining hope for long-term survival despite overwhelming rates of recurrence
was difficult for survivors undergoing pancreatic cancer surveillance scans. The dynamic
nature of holding out hope was multifaceted and may not be completely uncovered by the
power of language. The painting of Hope (Figure 2) completed by George Frederic Watts
(1886) captures the true quality of this theme and illustrates the deliberate act of
maintaining hope in the face of a deadly disease.
Hope in Art. In the painting Hope artist George Frederic Watts (1817 - 1904)
portrayed hope as a blindfolded female who sits alone on an unstable world, floating in
water. The woman appears to be on the brink of despair; she appears overcome yet not
defeated. She remains deeply seated on her world. She huddles over a lyre with only one
string. All other strings are broken, yet she is determined to play. She bends her ear to
hear the soft sound of her music. There is a single small star in the sky that she
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Figure 2
Painting to Illuminate the Essential Quality of the Hope for Lifelong Remission

cannot see. Her circumstances appear dismal, and her efforts seem in vain, yet she is not
deterred. She must find her hope from within. Hope is her instrument to play.
Similar to the symbolic representation of hope in the painting, the participants
held on to a distinct hope and belief in lifelong remission, despite the high likelihood of
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recurrent, incurable disease. Leaving room for hope enhanced coping strategies and
empowered survivors to keep going, as they continuously endured their surveillance
scans throughout their survivorship period.
Conceptual Framework
The essential themes uncovered in this research were: the recurring cycle of
scanxiety and the hope for lifelong remission. A conceptual model of the study themes
is presented in Figure 3. As shown in the model, the recurring cycle of scanxiety is a
four-stage process initiated about one week prior to an upcoming scan. Scan awareness
triggers increased anxiety and fears of cancer recurrence which influence the individual’s
emotional and behavioral responses. Mental preparation is the first stage of the cycle and
describes the preparations survivors make to ready themselves for their scan. Anxiety and
recurrence fears continue to rise and intensify in the interval between the scan procedure
and receipt of the scan result. Waiting to exhale describes the anxiety peak as survivors
anticipate their scan results. Following notification of a negative scan, anxiety and
recurrence fears nadir, and survivors are reassured their cancer has not returned. Proof of
life describes the evidentiary proof survivors require to decrease fears and resume normal
activities of daily life. The relief generated from the scan is short-lived, as survivors
recognize their need for future scans. Resetting the clock describes the reflexive rise and
stabilization of anxiety as survivors anticipate their next upcoming scan. The cycle is
centered around the survivors’ hope for continued remission. Hope allows survivors to
conceptualize a return to their pre-cancer life, which in turn motivates individuals to carry
on throughout each phase of the cycle.
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Figure 3
Conceptual Framework of the Recurrent Cycle of Scanxiety

Summary
Although the participants described vastly different experiences, the recurring
cycle of scanxiety and the hope for lifelong remission were etched into every
participant’s narrative. The cycle of scanxiety describes the complex repetitive sequence
of behavioral and emotional responses manifested by pancreatic cancer survivors during
times of their surveillance scans. Fear of cancer recurrence provides the backdrop for the

89

cycle and shaped the participants' responses as they moved through each phase of the
cycle. Finally, hope for lifelong remission describes the underlying driving force
propelling participants during diagnostic phases of survivorship. Maintaining hope
allowed the participants to hold on to the most positive outcome of complete and lasting
remission, often prompting a deliberate change in mindset which allowed for positive
growth throughout the cancer journey.
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CHAPTER FIVE
DISCUSSION

“I live with fear pretty much on a daily basis. Sometimes it’s in the back of my mind and
sometimes it’s in the forefront, but it’s always there. It’s frightening. It’s the unknown.
It’s waiting for the other shoe to drop.” (Leah, p. 16, lines 446 – 450).

The purpose of this study was to illuminate the lived experiences of scanxiety in
survivors of pancreatic cancer who have undergone curative surgical resection.
Eighteen survivors of pancreatic cancer participated and shared their personal
experiences as they underwent a CT scan. Participant interviews were digitally recorded
and transcribed verbatim. Hermeneutic phenomenology as applied by Heidegger (1962)
provided the philosophical foundation for this study, and van Manen’s phenomenological
approach (1990) was used to guide the research process. Thematic analysis uncovered
two essential themes: the recurring cycle of scanxiety and hope for lifelong remission.
The recurring cycle of scanxiety was introduced as a four-stage process describing the
complex sequence of events participants experienced during the time surrounding their
surveillance scans. Fear of cancer recurrence (FCR) was the primary source of scanxiety.
Continuous fluctuations in FCR were common and shaped the participants’ responses
throughout each phase of the cycle. Hope for lifelong remission served as the primary
objective of survivorship, offering a glimmering chance of a cure and keeping survivors
engaged throughout the cycle. A conceptual model was developed to provide a
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framework for understanding the participants' reactions to their scans. This chapter
summarizes the key findings derived from the study and compares and contrasts themes
with the current literature. The findings are discussed in the context of the Cancer
Recurrence Model (Lee-Jones,1997). The study limitations, implications, and directions
for future research are presented.
The Recurring Cycle of Scanxiety
During times surrounding a surveillance scan, the participants experienced
significant psychological distress that affected their physical and mental health, impaired
their social functioning, and reduced the quality of their lives. Heightened fears of cancer
recurrence and scan-related anxiety were extremely distressing and were reported by all
participants. Despite the debilitating nature of distress due to scanxiety, patient fears
seem to go unnoticed by oncology providers. The lack of recognition by healthcare
providers is not surprising. Scanxiety is a relatively new concept in the cancer literature
and is not uniformly recognized or measured in published studies (Bui et al., 2022). What
little is known about scanxiety is largely based on investigations evaluating the
psychological impact of cancer screening scans in healthy patient populations. Among
these studies, cancer screening scans have been linked to negative psychosocial
consequences in patients at high risk for developing breast, colon, lung, and pancreatic
cancers (Bui et al., 2021b; Overbeek et al., 2020; Rasmussen et al., 2015). In the few
studies where scan-related anxiety was explored in oncology populations, scanxiety was
reported in populations with lymphoma, breast, and lung cancers (Abreu et al., 2017;
Bauml et al., 2016; LoRe et al., 2016; Thompson et al., 2010). The prevalence of
scanxiety varies greatly, ranging from 37% in long-term lymphoma survivors (Thompson
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et al., 2010) to 86% in solid tumors of the lung, breast, and prostate (Grilo et al., 2017).
In a recent scoping review on the prevalence and contributing factors associated with
scanxiety, Bui et al. (2021a) identified several factors contributing to the increased
severity of scanxiety. Variables such as lower education, history of smoking, higher
perceived risk of cancer, and higher levels of pain were associated with higher scanxiety
severity. Interestingly, the prevalence or severity of scanxiety was not related to age,
gender, income, or marital status (Bui et al., 2021a).
There is a general lack of research on the impact of surveillance scans among the
pancreatic cancer population. To date, no published studies have explored the concept,
despite the debilitating psychological distress known to exist among persons with
pancreatic cancer (Watson et al., 2019). The exclusion of pancreatic cancer in the
scanxiety literature is discouraging, yet not surprising. Pancreatic cancer is largely underrepresented in psychosocial oncology literature, and further research is needed to address
the psychological needs of this patient population.
Fear of Cancer Recurrence
For study participants, the lived experience of undergoing a pancreatic cancer
surveillance scan began with fear. Fears of death, pain, further treatments, increased
toxicities, and being a burden to one’s family were symptoms of a deep-rooted primary
fear of the cancer returning. In the literature, fears of recurrence are highly prevalent
among cancer survivors regardless of cancer type or stage of the disease. There is a
considerable amount of literature demonstrating that most cancer survivors experience at
least some degree of FCR (Sharpe et al., 2018), especially among those with breast
(Schapira et al., 2021), lung (Lee et al., 2020), ovarian (Ozga et al., 2015), pancreatic
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(Petzel et al., 2012), prostate (Meissner et al., 2021) and colorectal cancers (Dang et al.,
2019). In the current study, increased FCR was commonly associated with increased
physical symptoms which survivors interpreted as signs of recurrence, creating a positive
feedback loop that further increased FCR. Misrepresentation of normal body symptoms is
a known consequence of FCR and often leads to continuous somatization which further
increases FCR and cancer-related distress (Tuman et al., 2021).
Influencing Factors
Impact of Wait Times. The time spent waiting for a scan result was described by
every participant as the single most important factor influencing anxiety around times of
scans. Survivors described increased anxiety, depression, and somatization during
extended wait times for scan results. These findings mirror those observed in earlier
studies which reported increased anxiety and emotional distress among patients who
waited longer than two days to receive radiology results (Woolen et al., 2018).
Conversely, several participants experienced shortened wait times and received their
results on the same day as their CT scan. This rapid diagnostic pathway not only
decreased anxiety while waiting for the scan result but also reduced anxiety and distress
in the days leading up to the scan. Survivors reported just "knowing" they would receive
the results immediately after their scan provided comfort and reduced pre-scan anxieties.
Wait time research in the oncology literature is limited, as research is primarily focused
on the diagnosis-to-treatment pathway and not on the length of time waiting on a
surveillance scan; however, in non-cancer populations, the negative psychological impact
of wait times has been reported. Extended wait times for medical test results are known to
induce physical and psychological distress and impair quality of life (Howell & Sweeny,

94

2016). In some cases, anticipating bad news may provoke more anxiety and distress than
actually receiving bad news itself (Sweeny & Falkenstein, 2015).
Impact of Time since Diagnosis. Research examining the trajectories of FCR
over time has not been consistent. Many studies have reported moderate to severe FCR
that lessens over time (Götze et al., Mulcahy2019, 2020; Leclair et al., 2019; Wu et al.,
2019), whereas other studies report FCR is stable over the course of survivorship or even
worsens five years out from diagnosis (McGinity et al., 2016; Schapira et al., 2021). The
findings from this study indicate the age of survivorship may impact the severity of
scanxiety over time. Two participants reported experiencing decreased scan-related
anxiety as their age of survivorship increased. As noted in the literature review, very little
is known about the course of scan-related anxiety over time. Research examining the
concept is limited since most studies used a cross-sectional design. The single-point in
time approach fails to explore temporal factors that may influence the prevalence and
severity of scanxiety over the survivorship trajectory.
Impact of Relationships. Social support is strongly linked to a better quality of
life during cancer survivorship (Aydın Sayılan & Demir Doğan, 2020). Surprisingly, in
the days leading up to the scan, the support of family and friends was not described as an
essential element to assuage scan-related fears. Preparing for an upcoming cancer scan
was largely described as a solitary experience, as many participants chose to keep scanrelated fears and concerns to themselves. This type of emotional withdrawal allowed
participants to limit triggering conversations that could increase scan-related anxiety. The
use of avoidance behaviors such as social isolation and emotional withdrawal was
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reported in the cancer literature and are maladaptive, leading to poorer health outcomes
(Hall et al., 2018; Jeong et al., 2016; Leung et al., 2021).
A critical finding in this study was the influence of the patient-provider
relationship on psychological wellbeing. It was important for survivors to perceive their
oncologists as trustworthy, knowledgeable, and highly skilled in the management of
pancreatic cancer. These factors helped lessen fears of recurrence and decreased scanrelated distress. This finding is not surprising and is strongly supported in the literature
(Blödt et al., 2021; Niranjan et al., 2020; Torbit et al., 2016; Truong et al., 2019). A
therapeutic patient-provider relationship is a critical component of high-quality, patientcentered care. Within the context of cancer, the relationship between the patient and the
oncologist is particularly important. Ongoing advancements and breakthroughs in cancer
research continue to yield more targeted drug therapies and multidisciplinary treatment
modalities which can overwhelm and unsettle patients and their families. Patients need to
perceive their provider as up to date with the latest advancements and as having the
primary goal of improving the quality and quantity of their life (Heuser et al., 2020; Kelly
et al., 2019). Participants who trusted their oncologist's ability to handle recurrent disease
believed having faith in their provider lessened their anxieties around the time of their
scan. Conversely, differing opinions and lack of communication among oncology
providers increased scan-related anxiety and uncertainty. Participants expected their
oncology providers to be in direct communication with one another and always "on the
same page". Several participants perceived some form of disconnect between their
medical and surgical oncologists. Often the perceived discrepancy stemmed from a
casual, off-hand comment made by one provider about another. Questions such as, "What
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did Doctor X think of your scan?" were perceived by the patient as a lack of
communication among providers and increased anxiety. A small number (2/18) of those
interviewed described provider disagreements over type and duration of adjuvant
chemotherapy, in which one oncologist expressed doubt over the other oncologist's
treatment plan. In these cases, participants worried their chemotherapy may not be
effective and experienced significant fears of recurrence and psychological distress that
lasted well beyond the interval of time surrounding the scan.
The Impact of Scan Procedure. Interestingly, the scanxiety experience largely
centered around the days leading up to the scan rather than the scan procedure itself. In
the participants’ descriptions of their scan experiences, they often left out the experience
of undergoing the scan procedure. Although many participants reported the
unpleasantness of drinking the oral contrast and the discomfort of being “stuck” by the
needle for the intravenous contrast, these discomforts were accepted as routine events
that are a normal part of cancer care. Bui et al. (2021a) reported similar study findings in
qualitative interviews among solid tumor cancer survivors in late-stage survivorship.
These findings are also supported in the quantitative literature (Abreu et al., 2017; Bauml
et al., 2016; LoRe et al., 2016) and indicate the source scanxiety may be entirely related
to the anticipation of scan result rather than the fear of the scan procedure.
Uncertainty in Illness
A key source of scanxiety stemmed from the uncertainty and unpredictability of
the disease. Most of the participants understood the incurable nature of a pancreatic
cancer recurrence, and this knowledge heightened a sense of uncertainty and provoked a
fear of cancer recurrence that shaped their response to the upcoming scan. Participants in
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the study exhibited distinctly different psychological and behavioral responses to their
scan with varying levels of severity. Participants who described themselves as needing to
be in control appeared to have more difficulty accepting the uncertainty surrounding the
surveillance scan period. Rotter's Locus of Control (LOC) Theory (1966) describes how
individuals discern the external influences impacting their lives. Individuals with an
internal LOC tend to see themselves as in control of their own circumstances and believe
their health outcomes are determined by their own actions. In contrast, individuals with
an external LOC view themselves as having little control over their circumstances and
believe their health outcomes are determined by external influences, outside of their
control. In persons with cancer, someone with an external LOC may be able to tolerate
uncertainty better than someone with an internal locus of control. Brown et al. (2017)
explored locus of control, mental health, and quality of life among terminal cancer
patients and found higher levels of LOC were associated with increased depression and
anxiety and decreased peace, faith, and hope. This finding is consistent with previous
uncertainty literature in which uncertainty in cancer is a known predictor of poor health
outcomes including increased physical and psychological morbidities (Ghodraty Jabloo et
al., 2017; Guan et al., 2020a, 2020b).
One unanticipated finding was the participants’ inconsistent preference for
certainty over uncertainty. Nearly every participant described an intolerance for the
uncertainty associated with a pancreatic cancer diagnosis, yet most (14/18) preferred “not
knowing” how recurrent disease would be managed. Only four participants preferred to
know the treatment strategy if a cancer recurrence was detected. This rather contradictory
finding may be explained by Mishel’s Uncertainty in Illness Theory (1988, 1990). Mishel
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describes the concept of “illness uncertainty” as a cognitive state which represents the
person’s inability to interpret illness-related events. Initially, illness uncertainty is viewed
as a neutral event. A person will appraise the uncertainty based on their own knowledge
and experience and will decide if the uncertainty represents a threat or an opportunity. If
an individual views the uncertainty as a threat or danger, they may seek ways to minimize
the uncertainty in order to gain control over the illness. If the individual appraises the
uncertainty as an opportunity, they may attempt to maintain the uncertainty by
perpetuating the ambiguity of their illness. The latter often occurs when the alternative to
uncertainty is negative certainty. For example, a patient with an extensive smoking
history and a new development of hemoptysis may refuse to seek care, preferring
uncertainty or not knowing to a possible diagnosis of lung cancer. Mishel’s theory may
explain why participants in this study feared uncertainty when there was hope for a
positive outcome, (i.e., negative CT scan indicating continued remission), but preferred
uncertainty in the context of a cancer recurrence, when the inevitable outcome would be
death from disease (Mishel, 1988, 1990).
Coping
Several coping strategies were described by participants as they prepared
themselves for their upcoming scan. Most of the participants described a process of
contingency planning which involved contemplating life plans if a cancer recurrence was
detected on their scan. This finding corroborates the qualitative research findings of
Latella et al. (2020) which described mental planning as an important coping mechanism
used to reduce FCR in lymphoma survivors. In the current study, participants alternated
contingency planning with the use of avoidant coping strategies aimed at distracting
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themselves from thinking about their upcoming scan. These results agree with the
findings in other studies in which avoidant-coping strategies were reported as a primary
method of reducing anxiety-provoking thoughts (Cohee et al., 2021; Inan & Ustun, 2018;
Latella et al., 2020).
Participants reported numerous external stimuli which disrupted distractioncoping methods and increased FCR. The host of the television show Jeopardy, Alex
Trebek, who died from pancreatic cancer during this study, was a commonly reported
trigger of FCR Other reported triggers included watching a commercial for cancer-related
therapies, reading cancer-related postings on social media, and receiving notifications
from healthcare providers. The negative psychological impact of cancer-related media on
the well-being of cancer survivors is well-documented in the literature. Numerous studies
have reported similar findings among survivors of breast, lung, colon, and prostate
cancers (Cohee et al., 2021; Latella et al., 2020; Luo et al., 2020; Şengün İnan & Üstün
Inan, 2018).
Hope for Lifelong Remission
The participants in this study experienced a distinct hope and belief in complete,
long-term remission and this hope made it possible to endure scan-related distress in the
days leading up to the scan. The hope for a complete recovery was implicit, and often
unspoken, yet was nurtured by every participant in the study. The surveillance scan
served as a mechanism to keep hope alive. Participants wanted to believe they could be
cured of their pancreatic cancer, and the surveillance scan provided a way to foster that
belief.
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Hope is an important coping strategy during a life-threatening illness and is
known to enhance coping skills and a sense of well-being (Corn et al., 2020). In cancer
populations, hope is widely reported as a protective factor against cancer-related distress
and is linked to positive mental health outcomes including decreased anxiety and
depression and increased quality of life (Baczewska, 2020; Grealish et al., 2019).
Although no previous study has investigated the concept of hope in survivors of
pancreatic cancer, there has been a considerable amount of literature published on the
benefits of hope in other cancer subtypes and throughout all stages of survivorship. In
quantitative studies, hope is positively associated with psychological resilience, a sense
of well-being, and enhanced adjustment to illness in breast, colorectal, and lung cancer
populations (Baczewska, 2019; Nieron-van Baalen et al., 2016, 2020; Y. Zhang et al.,
2020). Hope is a highly prevalent coping strategy in patients with advanced-stage
cancers; research has shown palliative care patients can have hope equally as strong as
curative patients (Baczewska, 2019, 2020; Nieron-van Baalen et al., 2016; Wang & Ling,
2016).
Factors Influencing Hope. Factors influencing hope were explored in several
studies. In a systematic review examining factors associated with hope during cancer
treatment, hope was positively associated with quality of life, social support, and spiritual
well-being and negatively associated with symptom burden, psychological distress, and
depression (Nierop-van Baalen et al., 2020). In a systematic review of the
biopsychosocial correlates of hope in Asian cancer populations, hope was positively
associated with income, performance status, and having an early-stage cancer diagnosis,
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and was negatively associated with fatigue, pain, and feelings of uncertainty (Mahendran
et al., 2016).
The primary object of hope for participants in the study was the expectation of
complete recovery from their cancer. Secondary objects of hope included the hope to
reach family milestones (e.g., weddings, the birth of a grandchild, etc.), to avoid further
treatments, and to recover from pain and toxicities of chemotherapy. Six participants
described a process of reframing hope in which the focus of hope was expanded to
include other more attainable outcomes such as the hope to live “one more day.”
Quantitative research has reported similar findings. In a cross-sectional study examining
the role of hope in persons with advanced cancer, Peh et al. (2017) reported on
reappraisals of hope throughout the cancer trajectory. Hope reappraisal was positively
associated with life satisfaction and inversely associated with affect. The hope
experienced by participants in the study was fragile and fluid; it was in constant flux in
response to several factors. Hope could be diminished by external stimuli such as hearing
about a cancer death in the news or unsolicited advice from a well-intentioned loved one.
This finding is consistent with the literature where hope is described as a
multidimensional and ever-changing process (Nierop-van Baalen et al., 2016, 2020; Petri
& Berthelsen, 2015). In a study of hope and healing in patients living with advanced nonsmall cell lung cancer, Eustache et al. (2014) described a process where hope was
diminished or lost entirely, regained, and reshaped as patients learned to live with their
advanced-stage diagnoses. Similarly, participants in this study experienced a continuous
change in levels of hope. Hope was maintained by a conscious effort on the part of the
participant. As the scan date approached, participants worked harder to keep hope alive.
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The surveillance scan served as a threat to hope before the procedure, but interestingly
became a source of hope afterward.
Participants described their surveillance scan as paradoxical in nature, on one
hand causing increased anxiety and fears of recurrence and on the other providing
reassurance and hope for a long-term cure. Surveillance scans were terrifying, yet they
offered survivors the chance of freedom from life-threatening illness and a path to
reclaim their pre-cancer lives. Contrary to previous literature in which patients perceived
their cancer scan as a “necessary evil” (Bui et al., 2021; Thompson et al., 2010), the
participants viewed their scan as a lifeline. The scans were symbolic of future birthdays,
graduations, Christmases, and vacations. When facing a disease with extremely low rates
of survival, surveillance scans provided passage out of the hopelessness of incurable
illness and into a life filled with the possibility of rebirth.
Conceptual Model of Research Findings
This research is the first to offer a conceptual framework to guide our
understanding of the lived experience of scanxiety. The comprehensive conceptual model
of scanxiety provides insight into how cancer survivors are affected by post-treatment
surveillance scans. The framework can be used as a resource to educate clinicians about
the critical time points surrounding a scan and to facilitate early recognition and
intervention for psychological distress.
Relevant Theoretical Framework
Each survivor’s experience of facing a surveillance scan was centered around a
fear of the cancer returning. The fear of cancer recurring was visceral and shaped the
survivor’s emotional and behavioral response throughout the scan period. The Fear of
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Cancer Recurrence Model (Lee-Jones et al., 1997) can be used as a framework to
understand how internal and external cues, cognitions, and emotions can impact how
pancreatic cancer survivors experience and respond to their surveillance scans.
Lee-Jones’s Fear of Cancer Recurrence Model
Theory provides a contextual framework for examining a specific phenomenon
through varying lenses. While there is not a conceptual model specific to scan-related
anxiety in cancer populations, the Self-Regulation Model of Illness (SRM) developed by
Leventhal et al. (1992) and later expanded by Lee-Jones et al. (1997) provides a useful
framework. As shown in Figure 4, the SRM describes the processes by which individuals
become aware of a health threat, navigate affective responses to the threat, and develop
coping strategies to manage the threat. The model posits that when individuals are
confronted with a health threat, an illness representation of two motivational processing
systems (cognitive and emotional) is constructed which act simultaneously to inform a
person’s response to the threat. The illness representation reflects the individual’s
common sense understanding of the health threat and is influenced by one’s memory and
personal experiences, and external sources of information. The individual’s illness
representation is then used to guide health-related decisions and behaviors. In this model,
the individual is viewed as an active problem-solver who must interpret two phenomena
simultaneously: (a) the perceived reality of the health threat and (b) the emotional
response to that threat (Leventhal et al.). Fear of cancer recurrence was later added to the
model by Lee-Jones et al. to explain how cancer-related fears and worries are processed
by cancer survivors.
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Figure 4
Leventhal’s Self-Regulation Model of Illness

In the expanded model, FCR is central and is influenced by an individual’s
internal cues such as physical symptoms and external cues such as follow-up office visits
and media sources of information. Cognitions include an individual’s perceived risk of
recurrence and are influenced by one’s personal knowledge of cancer (e.g., cure and
survival rates), past experiences of cancer and its treatments, and beliefs about the
eradication of initial cancer. Emotions are associated with concerns about cancer
returning, general anxiety over the cancer diagnosis, and regret over past treatment
decisions. An important contribution of this model is its ability to explain the
psychological and behavioral consequences of FCR. The psychological consequences
may include symptom misrepresentation (e.g., attributing neutral body symptoms as
evidence of cancer recurrence), increased somatic anxiety, or increased propensity to
panic attacks. Behavioral consequences can include excessive body checking (e.g.,
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anxious preoccupation with checking for signs and symptoms of cancer), overutilization
of the health care system (e.g., increased doctor visits, requesting scans), and limited
planning for the future. The Fear of Cancer Recurrence model describes how antecedents,
cognitions, and emotions can influence an individual's perceived personal risk for
recurrence, and how this perception can lead to behavioral and psychological
consequences (Lee-Jones et al., 1997).
As shown in Figure 5, the findings from the current study were mapped onto the
Lee-Jones et al. (1997) FCR model to evaluate its applicability to pancreatic cancer
survivors during times of surveillance imaging. Existing variables of the model that were
supported by the study findings are shown in red. Additional variables identified in this
study were added to the model and are highlighted in yellow. The adapted model
highlights the internal cues triggering FCR that were supported in this study which
include the presence of somatic symptoms, follow-up oncology appointments, and
exposure to cancer-related media such as television shows or social media postings.
Surveillance scans were incorporated into the model as an additional external cue
triggering FCR. Relevant cognitions supported by the qualitative interviews include the
patient's knowledge of pancreatic cancer survival rates, understanding of the risk of
cancer recurrence, and perception of what a recurrence might indicate (i.e., incurable
disease). Finally, the addition of avoidant coping and planning contingencies as
behavioral consequences and increased psychological distress as a psychological
consequence were supported by the study findings and incorporated into the model. The
resulting refined framework supports the applicability of the FCR model during times of
cancer surveillance scan imaging. The revised model increases our understanding of the
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Figure 5
Modified Fear of Cancer Recurrence Conceptual Model
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numerous factors influencing scan-related anxiety and can guide research in this
underexplored area.
Limitations
As with all qualitative research, the small sample size makes the findings less
generalizable to larger patient populations. In addition, the participant pool was limited to
a specific cancer population that received definitive treatment and had no evidence of
disease. The narrow scope of participants further limits generalizability to other cancer
populations. Pancreatic adenocarcinoma bears the distinction of being one of the
deadliest malignancies worldwide, with a high risk for recurrent disease and a low overall
survival rate. Other cancer populations with more favorable prognoses may not
experience their surveillance scans in the same way. Because the study was limited to
participants with no evidence of disease, it is unknown if similar scanxiety levels would
be reported in patients with advanced stages of the disease.
A second limitation is the lack of additional follow-up interviews with the
participants. Follow-up interviews were initially planned at the outset of the study;
however, changes in participant disease status limited subsequent interviews for many of
the participants. For example, throughout the study, nearly half of the participants (8/18)
either developed a recurrence of pancreatic cancer or died from the disease. For this
reason, the researcher chose to perform one-time interviews with each participant.
A third limitation was the lack of racial diversity in the sample. Although attempts
were made to increase the diversity of the sample, all 18 participants were Caucasian.
Consequently, this study cannot address whether the lived experience of pancreatic
cancer survivors undergoing cancer surveillance scans differs by race of the participants.
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A final study limitation involved the unexpected passage of the 21st Century
Cures Act (2020) on April 5, 2021. This legislation was enacted during study enrollment
after 11 participants had completed their interviews. This policy change enabled three
participants to view their scan results immediately, using the patient portal My Chart.
Passage of this federal law during the study altered the way participants received their
scan results and possibly influenced the results obtained. The time spent waiting for a
scan result was described by every participant as the single most important factor
influencing anxiety around times of scans. Patient portals eliminate prolonged wait times
which can exacerbate scanxiety symptoms. The three self-viewing participants received
their scan results immediately, which eliminated a prolonged wait time and gave rise to a
different scan experience. Further research is needed to explore the implications of the
21st Century Cures Act and the impact patient portals have on individuals undergoing
cancer surveillance scans.
Implications
Implications for Nursing Practice and Policy
The findings of this study have important implications for advancing nursing
knowledge of scanxiety in cancer populations. Scan-related anxiety can have a profound
impact on patients with cancer, as it affects their physical, psychological, and emotional
well-being, and subsequently decreases overall quality of life (Janda et al., 2017). In the
clinical setting, untreated anxiety interferes with a patient's cognitive functioning by
disrupting the processing of new information, impairing memory storage and recall, and
interfering with decision-making abilities (Kemp et al., 2020; Woolen et al., 2018).
Cancer surveillance scans provide important information regarding the patient’s response
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to therapy and overall prognosis. Patients with untreated anxiety may not be able to
accurately understand or interpret their scan results, thereby limiting their ability to
engage in shared medical decision-making with their provider (Derry et al., 2019;
Nguyen et al., 2019).
In the clinic setting, there is little understanding of the potential for psychological
harm during cancer surveillance scans; thus, patient concerns are not assessed. Cancer
distress screening is widely recognized as the sixth vital sign in routine cancer care
(Andersen et al., 2015) and was mandated for national cancer center accreditation in 2015
(American College of Surgeons Commission on Cancer [CoC], 2015). Despite these
guidelines, distress screening is not routinely performed during key times of cancer
survivorship. The current mandate requires cancer centers to screen individuals at least
one time during a "pivotal medical visit" which is defined as one of three time points
when patients are: (a) starting their initial cancer treatment; (b) transitioning to new
treatments (e.g., switching from chemotherapy to radiation therapy); or (c) transitioning
off treatments (CoC, 2016; CoC, 2020). The visits surrounding the time for surveillance
scans are not mentioned as possible high-distress visits and thus are not recommended
time points to evaluate for distress. Nursing is a key discipline within the healthcare
system to address this inadequacy. In the clinic setting, oncology nurses are wellpositioned to ask patients about any fears or concerns they may have about their
upcoming scans and to implement cancer-distress screenings to identify patients who
may be at risk. By helping to promote the use of routine distress screening during times
of diagnostic scans, nurses can recognize symptoms of distress early and provide the
supportive measures needed to improve quality of life across cancer patient populations.
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Implications for Research
The findings of this study add to a growing body of literature highlighting the
critical need for distress screenings during the diagnostic phases of cancer survivorship.
Post-treatment surveillance scans are an essential component to monitor for disease
recurrence, yet the psychological burden of these scans is underexplored in the cancer
literature. Scanxiety is a common clinical phenomenon and has been anecdotally
observed by oncology clinicians, widely reported in social media, and recognized among
many national cancer organizations (Ennis-O’Connor, 2018; Hillard, 2016; Portman,
2019), yet the term “scanxiety” is not part of the medical lexicon and subsequently is not
sufficiently defined, explored, or measured in published research studies (Bui et al., 2021;
Mulcachy, 2017). Some cancer populations may be at higher risk for psychological harm
from surveillance scans. Individuals with cancers associated with a poor prognosis and
high symptom burden such as pancreatic and lung cancers may be more likely to develop
scanxiety and require early psychological interventions during times of surveillance
imaging. Individuals with advanced-stage cancers represent a vulnerable high-risk
population and may also need additional support to effectively cope with upcoming
scans.
This study uncovered many questions in need of further investigation. A
considerable amount of research is needed to better understand the defining features and
contributing factors associated with scanxiety. Currently, there is no clear definition or
characterization of the term. Establishing a universal definition would provide a
foundation for future research and facilitate the development of a scanxiety measure that
could be used in empirical investigations and support the development of psychosocial
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interventions. Additional research is needed to explore the clinical significance of
scanxiety and to help clinicians recognize when scanxiety levels are clinically relevant
and require immediate psychosocial interventions. Further research is also needed to
identify high-risk populations and to understand the impact of scanxiety over time.
Conclusions
The purpose of this study was to explore the lived experience of survivors of
pancreatic cancer who underwent a surveillance scan to monitor for disease recurrence. A
recurring cycle of scanxiety and hope for lifelong remission were revealed as the essence
of living through a surveillance scan in the face of a pancreatic cancer diagnosis. The
results of this study enhance our understanding of the cancer-scan experience and
highlight the need for heightened awareness of scanxiety among oncology providers.
There is a fundamental need to improve our understanding of the psychological impact of
cancer surveillance scans to help guide the development of interventions and improve
outcomes across cancer patient populations.
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APPENDIX A
Summary of Studies Investigating Scanxiety in Cancer
Author
/ Year

Study
design

Sample
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Abreu
et al.,
2017

Longitudinal
Pre / posttest
design

n = 232

Bauml
et al.,
2016

Crosssectional

n = 103

Grilo et
al.,
2017

Longitudinal
Pre / posttest
design

n = 81

Heyer et
al.,
2015

Crosssectional

n = 825

LoRe et
al.,
2016

Lung, breast,
prostate, and
lymphoma

Mixed cancer and
non-cancer
population

n = 260
Mixed cancer and
non-cancer
population

Study findings

-Anxiety measured immediately
pre- and post-PET scan

-Higher anxiety scores prior to scan
-Anxiety higher in men and patients
without metastatic disease
-No significant differences found in age
or education

-Distress (IES6) and QOL
(FACT-L) measured immediately
prior to CT scan

Scan-distress reported in 83% of patients
and significantly impairs QOL (p<.004)
-Distress not associated with time since
diagnosis or results of prior scan
-No sociodemographic variables
associated with severity of distress

Anxiety (STAI) and scan
experience questionnaire (SEQ)
immediately pre- and post-PET
scan

-Higher anxiety scores post-scan
-Scan results are primary source of
anxiety
-No significant differences between
patients undergoing first-time scan

Anxiety (STAI-S) measured
immediately prior to CT scan.
10 additional questions given to
measure concerns specific to CT
scan procedure

-Scan anxiety exists and related to fears
of contrast agents, radiation exposure and
claustrophobia
- Anxiety higher in women, first time
scanners, patients receiving IV contrast
and patients with solid tumors

Anxiety (STAI) measured
immediately prior to CT,
mammography, MRI, US, X-ray

-Anxiety present in 91% of patients
-Anxiety higher in women, non-cancer
patients and patients undergoing US

Mixed cancer
population

Recurrent or
metastatic lung
cancer

Crosssectional

Methodological
considerations

Comments
No validated
instruments
used

Anxiety in
US possibly
related to
immediate
test results

Author/
Year

Study
design

Sample

McGinty
et al.,
2016;

Longitudinal
7 time points
over 2
months

n = 161

Pifarre et
al., 2011.

Crosssectional

n = 200

Breast cancer,
Stage 0-3A, within
3 years following
primary treatment

Mixed cancer
population
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Thompson
et al.,
2010

Crosssectional,
mixed
methods

n= 70 Quant/ n=30
qual Adult
lymphoma
survivors > 2 years
out from cancer
treatment

Yu et al.,
2011.

Crosssectional

n = 398
Mixed cancer
population

Methodological
considerations

Study findings

Comments

Fear of recurrence (FCRI, CWS)
and anxiety (VAS1, VAS2)
measured at various time points
before and after routine
mammography

- Severity of FCR and anxiety
significantly change over time
- Scores increase prior mammogram,
decreased after mammogram and
increased again 1 month after.

Anxiety (STAI) measured
immediately prior to PET-CT
scan.

- Anxiety present in 67.5% of patients
undergoing PET-CT
-Higher anxiety in men, initial cancer
staging, and if staging for metastatic
disease

Lower anxiety
in patients
with known
mets and
receiving
treatment

- Clinically significant anxiety in 37%
patients
-Anxiety positively associated with
worse provider relationship and history
of relapse
- Qualitative interviews found anxiety
peaks prior to scan, resolves after scan
and related to FCR
- No clinical or sociodemographic
variables associated with anxiety

Data collection
not related to
timing of
upcoming scan

-Anxiety (STAI) and patient
provider relationship measured in
outpatient oncology setting
-Subset of patients qualitatively
interviewed and asked to
describe personal experiences
with scan

Anxiety (STAI and HADS)
given immediately prior to CT,
mammography, MRI, US, X-ray

Anxiety present in 46% of patients
undergoing diagnostic imaging
-Anxiety higher in women, younger
patients and lower SES
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APPENDIX C
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APPENDIX D

Interview Guide--Lived Experience of Surveillance Scans
Preliminary questions:
“When you have an upcoming surveillance scan, do you find yourself thinking about the
scan more than twice a day?
“Are you comfortable sharing your personal experiences with your scans?”
Interview Questions:
1. Since receiving your diagnosis, tell me about your experience as a survivor of
pancreatic cancer.
DAYS LEADING UP TO SCAN
2. Can you describe the days leading up to your scan?
•
•
•
•
•
•
•
•
•
•

How do you generally know when it’s time to have your scan?
Who orders this scan?
How do you remember the date?
Experience with medical staff?
Do you tell others about your upcoming scan?
How do you pass the time in days leading up to your scan? *Physical /
Behavioral changes prior to scan
Do you find yourself thinking about your scan often?
Do you notice any changes in your emotions before your scan?
Does your family notice any changes in you prior to your scan?
Any coping strategies used

THE SCAN
3. Describe the day of your scan.
4. Transportation to scan
5. Alone or accompanied?
6. Describe the scan procedure
•
•
•
•
•

Do you do ok with IV and contrast?
Radiology Dept staff demeanor?
Radiology staff competency?
What do you think about when you are in the CT scanner?
What is your emotional reaction to scan procedure?
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RESULTS
7. How do you get your scan results?
• How long do you have to wait?
• How do you pass the time while you wait?
• Do you prefer to be with people or alone?
• How do you react emotionally to the wait?
• What things do you think about?
8. Have you ever found out results from patient portal?
•
•

If so, describe this experience?
Would you rather know immediately or wait until Dr can tell you and hear
his impression / recommendations?
9. What information was given to you when you received your results?
10. What was your emotional reaction to the results?
• Physical / behavioral reaction? (holding someone’s hand, clenching fist?)
11. How did the staff treat you in the Dr’s office?
• Were you treated any different from other non-scan visits?
12. After leaving the Dr.’s office, did you feel like you properly understood your
results?
13. Afterward, what did you do after receiving your scan results?
OVERALL EXPERIENCE
14. Are there any factors that influence your experience with your scans?
15. Tell me about your experience during non-scan times.
16. Do your scans hold any meaning for you?
17. Describe what things may help you cope?
18. Is there any aspect of the scan experience you find most difficult?
19. Is there anything you do to help yourself (emotionally or physically) prepare for
your upcoming scans?
20. Are there any factors that hinder your coping during this period?
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APPENDIX F
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APPENDIX G

Essential Themes and Subthemes of the Lived Experience of Scanxiety
Theme and Description

Subthemes

Recurring cycle of scanxiety
A complex repetitive pattern of behavioral
and emotional responses manifested by
survivors during the time surrounding their
surveillance scans.

Fear of cancer recurrence
Mental preparation
Proof of life
Waiting to exhale
Resetting the clock

Hope for lifelong remission
The intense desire for a complete recovery
and a return to normal life.
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Balancing fatalism and optimism
Reframing hope
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